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INTRODUCTION 
Review of Smoking Literature 
Authorities view smoking as the number one health problem in the 
United States today (Pechacek & Danaher, 1979). It certainly appears 
to be the leading preventable cause of death. Recent epidemiological 
and biomedical research indisputably identifies smoking as a 
significant causal factor in numerous serious diseases, including 
lung cancer (Doll & Hill, 1964; Horn, 1968a), coronary heart disease 
(Doll & Hill 1964; Doll & Peto, 1976; Friedman, Dales, & Ury, 1979; 
USPHS, 1979), emphysema, chronic bronchitis, ulcers, and various 
cancers (Horn, 1968a; USPHS, 1978, 1979). Investigators estimate 
that more than 37 million Americans will die prematurely as a result 
of smoking (Pollin, 1977; USPHS, 1977, 1978). 
Most smokers are aware of the health risks associated with smoking 
(Gallup Opinion Index, 1974). In a literature review, Lichtenstein 
and Danaher (1976) reported that at least one-half of the adult 
smokers would like to or have seriously attempted to break their 
smoking habits. Further, they estimated that only 25% of smokers 
who tried to quit were successful (Lichtenstein & Danaher, 1976). 
Thus, the problem does not appear to be lack of awareness, but lack 
of success. 
Due to increasing concern about smoking, research concerning 
empirical treatments and theoretical models has proliferated in 
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recent years. Educational campaigns, pharmacological substances, 
hypnosis, aversion techniques, nicotine-fading procedures, and 
multicomponent packages are among the wide variety of interventions 
used to treat smokers. In addition, numerous investigators have 
delineated theoretical models in an attempt to explain smoking 
behavior and to categorize smokers' personalities (Eysenck, 1973; 
Horn, 1968b; Ikard, Green & Horn, 1969; McKennell, 1968, 1970; 
Russell, 1971a, 1971b; Schachter 1978, 1980; Tomkins, 1966, 1968). 
Finally, other researchers have focused specifically on the relapse 
process associated with smoking (Marlatt, 1980; Marlatt & Gordon, 
1980; Shiffman, 1982). 
Early research in the area produced almost uniformly disappointing 
results (Bernstein, 1969; Hunt & Matarazzo, 1973), However, due to 
improvements in both treatment methodology and outcome data, recent 
reviews are more optimistic about smoking treatments (Bernstein & 
Glasgow, 1979; Lichtenstein & Danaher, 1976; Lando, 1980; Pechacek, 
1979). Smokers demonstrate an impressive decrease in smoking during 
treatment, whether the criterion is cessation or significant reduction 
in smoking (Lando, 1980; Leventhal & Cleary, 1980). However, the 
long-term efficacy of these treatments remains problematic. Leventhal 
and Cleary (1980) estimated that as few as 10 to 25% of subjects 
remained abstinent at 12-month follow-up periods, although higher 
rates have been reported (35 to 45%). The high recidivism rates 
suggest that treatment strategies aimed at long-term maintenance of 
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nonsmoking need further development and testing. 
Nonbehavioral treatments 
Researchers and clinicians have developed numerous treatments 
to aid smokers in quitting smoking. For example, Pechacek (1979) 
noted that changes in patterns of smoking (e.g., switching to filter 
cigarettes) were attributable to information and education campaigns. 
However, only 10% of the exsmokers not attending clinics credited 
mass media efforts for their stopping (Pechacek, 1979). In addition, 
several public service clinics (e.g., American Cancer Society, 
American Lung Association) have offered treatments aimed at helping 
smokers break the habit. 
Investigators have also searched for pharmacological agents 
(e.g., lobeline, nicotine chewing gum) to substitute for nicotine 
and minimize withdrawal symptoms. Although early efforts were 
frustrating as most drugs were used in combination with other 
treatments and did not appear to improve long-term success rates 
(Schwartz & Rider, 1977), more recent efforts with the nicotine 
chewing gum have been more promising (Russell, Raw, & 
Jarvis, 1980). 
Finally, hypnosis has been used to treat smokers for more than 
30 years (Bernstein & McAlister, 1976). Although some researchers 
have criticized the use of hypnosis for inadequate follow-up data 
(Schwartz & Rider, 1977) and methodological problems (Pechacek, 1979), 
Holroyd (1980) reported positive findings in a review investigating 
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the components incorporated into successful hypnotherapies. The 
most salient variable in the successful studies was tailoring the 
suggestions to the smoker's individual needs and motivations. 
Abstinence in the tailored groups ranged from 60 to 88% at 6-month 
follow-up (Holroyd, 1980). 
Behavioral treatments 
A diversity of behavioral treatments have been aimed at 
smoking populations, including: sensory deprivation (e.g., Suedfeld 
& Ikard, 1974), systematic desensitization (e.g., Koenig & Masters, 
1965), stimulus control (e.g., Levinson, Shapiro, Schwartz, & Tursky, 
1971), reinforcement for nonsmoking (e.g., Tooely & Pratt, 1967), and 
aversive conditioning (e.g., Lichtenstein, Harris, Birchler, Wahl, 
& Schmahl, 1973; Resnick, 1968). Although the initial focus was 
exclusively on smoking cessation, recent investigators have developed 
multicomponent and cognitive-behavioral interventions designed for 
both cessation and maintenance (e.g. Boelens, 1980; Lando, 1978). 
In summary, the majority of the empirical research has involved 
aversion strategies, self-management techniques, and multicomponent 
packages. 
Aversion. The most common cessation interventions use aversive 
stimuli (electric shock, covert sensitization, and cigarette smoke). 
Laboratory researchers have favored electric shock because it 
is easily quantified and manipulated. Although a few positive results 
have been achieved (Dericco, Brigham, & Garlington, 1977), most 
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treatments relying upon electric shock have proven ineffective 
(Bernstein, 1969; Lando, 1980; Lichtenstein & Danaher, 1976; 
Pechacek, 1979; Schwartz & Rider, 1977). Lichtenstein and Keutzer 
(1971), in a literature review, concluded that the ineffectiveness 
of laboratory-administered shock was because "humans appear to 
be all too capable of discriminating between shock and no-shock 
situations and the hoped for generalization never materialized" 
(p. 63). In a comprehensive study, the effects of contingent 
shock were not superior to noncontingent shock, leading researchers 
to suggest that the traditional conditioning processes were 
inoperative in smoking behavior (Russell, Armstrong, & Patel, 1975). 
Finally, Wilson and Davison (1969) stated that aversion strategies 
should have an intrinsic relationship to the target behavior to 
be effective. 
Covert sensitization, the second aversion technique, requires 
the smoker to vividly imagine smoking followed by unpleasant 
sensations, such as nausea and vomiting (Cautela, 1967). Although 
case studies using covert sensitization have appeared promising, 
controlled investigations have proven relatively ineffective at 
long-term follow-ups (Bernstein & McAlister, 1976; Pechacek, 1979; 
Schwartz & Rider, 1977). A recent investigation, supporting this 
conclusion, found that pairing an actual cigarette with the 
aversive imagery was initially effective (80.5% reduction in smoking), 
but treatment effects were absent at the 2-month follow-up 
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(Lichtenstein & Sallis, 1981), However, it is possible that covert 
sensitization may have value in multicomponent packages. 
The third type of aversion strategies, rapid smoking and 
satiation,.involve the use of cigarette smoke. Rapid smoking 
requires smokers to puff on a cigarette once every six seconds until 
they are unable to continue. Lichtenstein and his colleagues 
(Harris & Lichtenstein, Note 1; Lichtenstein et al., 1973; Schmahl, 
Lichtenstein, & Harris, 1972; Weinrobe & Lichtenstein, Note 2) 
have reported the most success with this technique, with initial 
success rates of approximately 95% and 60% abstinence rates at 
6-month follow-ups. However, similar studies conducted in other 
laboratories have not replicated these results (Flaxman, 1978; 
Lando, 1975, 1976a, 1976b; Lèvenberg & Wagner, 1976), calling the 
efficacy of the procedure into question. In addition, Lichtenstein 
and Rodrigues (1977) reported only 34% abstinence at longer follow-
ups (2 to 6 years). Further, of the 33 subjects reporting abstinence, 
20 stated they had smoked since the termination of treatment. Thus, 
the role of rapid smoking in long-term abstinence is unclear. 
Finally, the efficacy of the rapid smoking technique itself is 
clouded by the inclusion of nonspecific treatment variables, 
including a warm personal client-therapist relationship, verbal 
praise, and high expectations of success. 
In addition, Resnick (1968) reported a satiation procedure 
requiring smokers to greatly increase their normal smoking 
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consumption for one week. The rationale behind this technique was 
that smoking would become aversive, thus decreasing the reinforcement 
value. Although Resnick (1968) reported 60% abstinence at the 4-month 
follow-up, more recent studies have not replicated these results 
(Lando, 1980). However, recent research has suggested that satiation, 
within a multicomponent package, can produce impressive results 
(Best, Owen, & Trentadue, 1978; Lando, 1977). 
Potential disadvantages of rapid smoking and satiation involve 
medical risks as both procedures were designed to produce physio­
logical discomfort. Researchers found that rapid smoking produced 
an immediate and dramatic effect on heart rate, blood pressure, and 
blood gases (Lichtenstein & Glasgow, 1977). Research concerning 
the medical risks of satiation found that heart rates were not 
effected, but carbon monoxide levels were increased (Lando, 
McCormack, & McGovern, Note 3). Clearly, both procedures require 
medical screening and are contraindicated for individuals with 
cardiovascular or pulmonary diseases (Lando, 1980; Pechacek, 1979). 
Self-management techniques. Self-management techniques require 
smokers to participate more actively in defining and implementing 
the treatment than aversion therapies. First, the client becomes 
more aware of the target behavior and its controlling stimuli through 
self-monitoring. Although self-monitoring alone has rarely 
produced more than temporary results (Pechacek, 1979), it has been 
widely used in multicomponent packages for baseline measures 
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(Boelens, 1980; Lando, 1977). 
Next, self-management skills are utilized to modify the frequency 
and/or topography of the behavior. Contingency contracting, a 
widely used technique, requires the smoker's agreement that specific 
consequences will occur for performance or nonperformance of smoking 
behavior. Researchers have used several types of contracting with 
smokers. For example, smokers have deposited money and its return 
was contingent upon attaining specific goals related to smoking 
(Elliot & Tighe, 1968). Lando described two types of contracting 
which were used in his laboratory (Lando, 1976c). The first contract 
was for one month and required the smoker to pay a certain amount 
of money per cigarette smoked to an organization of his/her choice. 
The second contract involved rewarding the smoker for not smoking 
or punishing the smoker for smoking and was rewritten weekly. 
Elliot and Tighe (1968), in an uncontrolled study, required 
undergraduate smokers to deposit $50 or $65 as guarantees of 
abstinence for 12 or 16 weeks, respectively. Although subjects 
reported a high abstinence rate initially (86%), 17-month follow-
up found only 35% of the subjects abstinent. In a more carefully 
controlled study, Winett (1973) achieved 50% abstinence at the 6-month 
follow-up. A recent study (Murray & Hobbs, 1981) compared 
self-punishment, self-reinforcement, a combination of the two, and 
self-monitoring. Results indicated that the combination of self-
punishment and reinforcement was significantly more effective than 
9 
either technique alone or self-monitoring. Although the combination 
produced only moderate abstinence rates at the 3-year follow-up, 
the results lend support to Lando's treatment package (Lando, 1976a, 
1977, Lando & McCullough, 1978) as the combination contingency 
contracting group was similar to Lando's contracting procedures 
which use both self-reinforcement and self-punishment techniques 
•(Lando, 1976c). In summary, when contingency contracting was 
the only intervention, modest results appeared, but when used within 
a multicomponent treatment package, contracting has enhanced 
treatment effectiveness (Lando, 1977; Lindsay, 1978). 
Stimulus control is another self-management procedure. By 
systematically altering the stimulus situations associated with 
smoking (e.g., after meals, social occasions, after sex) or 
by bringing smoking under the control of an external cue (e.g., 
time), researchers have attempted to control smoking behavior. 
Presumably, decreasing the strength of the association between 
smoking and various controlling stimuli would facilitate abstinence. 
Unfortunately, little evidence exists favoring the use of 
stimulus control techniques (Lando, 1980; Lichtenstein & Danaher, 
1976). Although individual case studies have reported success, 
stimulus control techniques have typically resulted in a temporary 
reduction in smoking followed by a rapid relapse (Pechacek, 1979). 
In addition, the value of stimulus control in multicomponent 
packages has proven disappointing (Flaxman, 1978). 
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Although the use of behavioral interventions has proven 
effective at helping people quit smoking, the problem of long-term 
abstinence still plagues smoking researchers. Recent research has 
combined self-control coping strategies with other behavioral 
interventions to enhance the effectiveness of the treatments over 
longer follow-up periods. Thus, the current trend in smoking 
research has been in the direction of multicomponent packages. 
Multicomponent treatments. Despite mixed results, the trend 
in reported outcome for multicomponent treatments has been encouraging. 
One study (Brengelmann, unpublished, cited in Lichtenstein & 
Danaher, 1976) included 37 self-control procedures (e.g. limiting 
smoking to certain times and places, changing brands daily). With 
the inclusion of contingency contracting, the effectiveness of 
the program increased to 58% abstinence at 2-month follow-up. A 
treatment-by-mail approach also produced positive results from 
self-control procedures with 86% of the subjects completing the 
treatment and 57% reporting abstinence at follow-up (Brengelmann & 
Sédlmayr, 1977) . However, the results of this study were not verified. 
In a carefully evaluated clinical study (Pomerleau, Adkins, 
& Pertschuk, 1978) which included a baseline period, a cessation 
treatment (reduction using daily quotas, stimulus control, and 
contingency management), and a maintenance treatment (covert 
conditioning, reviewing reasons for abstinence, social reinforcement, 
and encouragement) 61% of the subjects were abstinent at the end 
of treatment. However, this rate decreased to only 32% at 1-year 
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follow-up, demonstrating problems with recidivism in multicomponent 
packages. 
Several other investigations have provided support for the 
efficacy of multicomponent packages utilizing self-management 
techniques. Conway (1977) reported that self-management plus 
aversion was more effective than the single interventions. 
Similarly, Lando (1976a) reported that combining aversion with 
contractual management enhanced the treatment outcome, although 
this effect was no longer evident at the 6-month follow-up. 
Flaxman (1978) used a self-management program and a specific target 
date for quitting and reported a 50% abstinence rate at the 6-month 
follow-up. Finally, Elliot and Denney (1978) found that a multi-
component package (including rapid smoking, covert sensitization, 
self-control strategies, and systematic desensitization) evidenced 
significant superiority at the 6-month follow-up when compared to 
a rapid smoking treatment group. 
Lando and his colleagues have conducted a number of investigations 
concerning the efficacy of various multicomponent interventions. 
Lando (1977) conducted a treatment program consisting of aversive 
conditioning (excessive smoking), contingency contracting, group 
support, and booster sessions in the event of relapse (rapid smoking). 
A comparison group received only the aversive treatment. At the 
6-month follow-up, 76% of the multicomponent treatment group reported 
abstinence, whereas only 35% of the aversion only group reported 
not smoking. The experimental design precluded isolating the 
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effective treatment components. 
Further investigations were concerned with evaluating the 
differential effectiveness of more complex programs versus treatments 
with fewer interventions. Lando (1978) found that the addition of 
fear appeal and stimulus control techniques to the aversion plus 
maintenance package was not successful. Similarly, another study 
reported a trend favoring a 2-stage program (aversion and maintenance) 
over a more complex 3-stage program (preparation, aversion, and 
maintenance) (Lando, Shirley, Gregory, & McCullough, Note 4). In 
evaluating these studies, it appears that a program combining too 
many treatment components can actually decrease its effectiveness 
(Lando, 1980; Lichtenstein & Danaher, 1976). At the same time, 
multicomponent packages have proven more encouraging than the 
treatments involving single interventions (Lando, 1980; Pechacek, 
1979). 
Treatment innovations. Two new areas of research in smoking 
include nonaversive cessation techniques and process variables 
operative within behavioral treatments. First, Foxx and Brown 
(1979) described a nicotine fading procedure which requires the 
subjects to systematically change their cigarettes to successively 
lower tar and nicotine brands. The first week involves a 30% 
reduction of nicotine from baseline; weeks two and three require a 
60% and 90% reduction, respectively. At the end of the third week, 
smokers are encouraged to quit smoking. 
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Foxx and Brown (1979) reported an abstinence rate of 40% at the 
18-month follow-up for a nicotine fading/self-monitoring group. 
Even more encouraging, this abstinence rate was maintained at the 30-
month follow-up (Foxx, Brown, & Katz, 1981). Finally, the non-
abstainers were smoking cigarettes lower in tar and nicotine than 
their pretreatment brands, and 60% were smoking fewer cigarettes 
than their baseline rates (Foxx et al., 1981). 
A preliminary study in Lando's laboratory (Lando, Etringer, 
McCormack, & Gregory, Note 5) compared the aversion procedure 
(satiation), the nicotine fading procedure, the nicotine fading 
plus a smoke-holding technique (Kopel, Suckerman, & Baksht, Note 
6), and the nicotine fading only procedure. The first three 
conditions included Lando's maintenance package (Lando, 1977, 1978) 
using group support and contingency contracting. The fourth 
condition replicated Foxx and Brown's original study (Foxx & 
Brown, 1979). Initial abstinence rates in all conditions were 
encouraging with 60% of the subjects reporting abstinence. At 
3-month follow-up, the nicotine fading plus smoke-holding 
group and the aversion group reported the most success, with 
63% and 46% of the subjects abstinent, respectively. Although 
the nicotine fading plus maintenance group and the nicotine fading 
only group reported less success (37% and 32% abstinence, respectively), 
the nicotine fading procedure clearly merits further testing. 
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The nicotine fading procedure has two potential advantages. 
First, smokers are probably exposed to less health risks during 
the fading treatment than during aversion therapies. Thus, the 
fading approach may be applicable to all smokers regardless of 
health problems. Second, if smokers do relapse, their return to 
lower tar and nicotine cigarettes (Beaver, Brown, & Lichtenstein, 
1981; Foxx et al., 1981) may prove less harmful to their health 
than relapsing to higher tar and nicotine cigarettes. 
This last issue is controversial as some evidence has suggested 
that changes to lower tar and nicotine cigarettes may not result in 
decreased health risks (Hammond, Garfinkel, Seidman, & Lew, 1977; 
Russell, 1974, 1976; Schachter, 1978). Specifically, some 
investigators have found that smokers increase their rate of 
cigarette consumption in order to compensate for the decreased 
nicotine intake (Frith, 1971; Goldfarb, Gritz, Jarvik, & Stolerman, 
1976; Schachter, 1977). Also, tentative evidence has suggested 
that smokers may modify topography variables after switching to 
lower tar and nicotine cigarettes. For example, smokers may increase 
the number of puffs per cigarette (Ashton, Watson, Marsh, & Sadler, 
1970; Schachter, Kozlowski, & Silverstein, 1977) and they may 
increase the puff volume (Frith, 1971; Kumar, Cooke, Lader, & 
Russell, 1977). 
In contrast, other investigators have not reported compensatory 
increases in cigarette smoking when smokers change to lower tar and 
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nicotine cigarettes (Beaver et al., 1981; Cherry & Forbes, 1972; 
Freedman & Fletcher, 1976). Additional evidence has suggested 
that topography changes in smoking, which accompanied switching to 
lower tar and nicotine cigarettes, resulted in decreased rather 
than increased biochemical exposure when measured by carboxy-
hemoglobin levels (Turner, Sillett, & Ball, 1974). In a 
well-controlled physiological study, Prue, Krapel, and Martin 
(1981) examined the effects of progressively reducing the tar 
and nicotine content of cigarettes. They measured carbon 
monoxide levels (Frederiksen & Martin, 1979) and saliva thiocyanate 
levels (Prue, Martin, & Hume, 1980). Both measures directly assess 
exposure to harmful gases consumed while smoking. The study 
concluded that the nicotine fading procedure resulted in con­
comitant decreases in the intake of poisonous gases. Although 
the theory that smoking lower tar and nicotine cigarettes involves 
diminished health risks is still controversial, this study 
provided strong support for it (Prue ét.al.., 1981) and for the 
efficacy of the nicotine fading procedure. 
The second innovative area in behavioral research involves 
investigating the effects of process variables on treatment outcome. 
Etringer, Gregory, and Lando (Note 7) manipulated group cohesion, 
a therapeutic relationship factor, in treatment groups including 
cessation (aversion and nicotine fading) and maintenance (group 
support and co.itingency contracting as delineated by Lando, 1975c). 
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Preliminary results indicated that increasing cohesion enhanced the 
effectiveness of both cessation treatments. Specifically, 
subjects in the structured cohesion groups maintained a percentage 
reduction from baseline smoking rate of 74% at the 3-month follow-
up, as compared to only 44% reduction in the unstructured cohesion 
groups. Further, the cohesion manipulation enhanced the nicotine 
fading technique so much that it was as effective as the satiation 
procedure at the 3-month follow-up. Given previous findings 
(Lando et al.. Note 5), this result was particularly impressive. 
It appears that further investigation of group cohesion, and 
other process variables active in behavioral treatments, may be 
a fruitful area in future research. 
Concluding remarks. In summary, behavioral treatments for 
cigarette smoking have become more sophisticated in recent years. 
Multicomponent packages appear to be the most effective interventions. 
In addition, the satiation procedure within a multicomponent frame­
work has produced impressive results (Best et al., 1978; Lando, 1977; 
Lando & McCullough, 1978). The possible health risks inherent in 
the aversion procedures have led researchers to develop nonaversive 
techniques. For example, Foxx and Brown (1979) described a nicotine 
fading procedure which appears to diminish health risks both during 
treatment and during relapse because smokers return to lower tar 
and nicotine cigarettes (Beaver et al., 1981; Foxx et al., 1981; 
Prue et al., 1981). 
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Finally, investigators have begun to study the impact of process 
variables operative within behavioral treatments. The importance 
of nonspecific treatment variables, such as the therapeutic 
relationship, verbal praise, and expectations of success, was 
noted in rapid smoking studies, but not studied (Lichtenstein & 
Rodrigues, 1977). More recently, one study, manipulating group 
cohesion in behavioral treatments, found that increased cohesion 
improved the effectiveness of the treatments (Etringer et al.. 
Note 7). Thus, these nonspecific process variables warrant 
further investigation. 
Although current smoking programs have demonstrated an 
impressive decline in smoking during the treatment, long-term 
maintenance of nonsmoking behavior continues to be problematic 
(e.g., Lando, 1980; Leventhal & Cleary, 1980; Marlatt, 1980). 
Focusing on individualizing treatment through the use of assessment 
devices and training smokers in cognitive-behavioral strategies 
to prevent relapses might improve long-term abstinence rates. 
The theoretical literature has provided assessment devices, 
information concerning the relapse process, and knowledge of 
coping strategies applicable to nonsmoking. Incorporation of 
the theoretical literature into a treatment format may result 
in more effective long-term treatments. 
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Review of Theoretical Issues 
Assessment devices. The psychological models of smoking have 
been based mainly on factor analyses of smokers' self-report data. 
In an early model, Tomkins (1965) presented a theoretical rationale 
for differentiating types of smoking behavior. Tomkins (1966) 
delineated four types of smoking: (1) smoking to increase positive 
affect, (2) smoking to reduce negative affect, (3) habitual 
smoking (with no affective component), and (4) addictive smoking 
(including both positive and negative affects). 
Within Tomkins' model (1966) smoking was viewed as a learned 
response which could be associated with any positive or negative 
affect. For the positive and negative affect smokers, cigarette 
smoking was used to regulate internal emotional states across 
a variety of situations. For example, smoking to increase positive 
affect resulted in stimulation or relaxation, while negative 
affect smoking resulted in reducing feelings of distress or fear. 
Habitual smoking involved a minimal degree of awareness, with the 
smoker possibly being oblivious to the act of lighting a cigarette. 
Finally, Tomkins (1966, 1968) hypothesized that dependence or 
addiction developed by the sequential linking of negative and 
positive emotional states. Specifically, the smoker experienced 
a negative emotional state and smoked to produce a positive affect 
that decreased the negative feelings. Addictive smokers were 
aware of not smoking which was accompanied by a negative affect state. 
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Thus, the absence of cigarettes generated negative feelings which 
reinstated smoking and this became a self-reinforcing system. 
The Horn-Waingrow Scale (Horn & Waingrow, Note 8; Appendix A) 
was devised to differentiate among the typology of smoking motives 
proposed by Tomkins (1968). The Horn-Waingrow Scale has been 
administered to college students (Coan, 1967), smokers attempting 
to quit (Ikard et al., 1969) and factor analyzed with large 
samples (Bosse, Garvey, & Glynn, 1980; Coan, 1969; Ikard et al., 
1969). These factor analytic studies have resulted in six 
factors or motives for smoking: reduction of negative affect, 
addiction, habitual, stimulation, pleasurable relaxation, and 
sensori-motor manipulation. These motives subsume and extend 
Tomkins' original theoretical paradigm (Tomkins, 1966). In 
addition, further support for Ikard et al.'s (1969) six motives 
for smoking was provided by Costa, McCrae, and Bosse (1980) 
when they administered a 43-item questionnaire in an attempt to 
extend the affect management model. The factor analysis replicated 
the six factors described above. 
Validity studies have also been conducted on the Horn-
Waingrow Scale. Laboratory studies have provided support for the 
negative affect, stimulation, pleasurable relaxation, and habitual 
subscales (Ikard & Tomkins, 1973; Leventhal & Avis, 1976). In 
addition, a clinical study which correlated smokers' self-monitored 
reasons for smoking with their scores on the scale provided 
support for the negative affect and sensori-motor scales (Joffe, 
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Lowe, & Fisher, 1981). 
In contrast, negative findings have also been reported. 
Adesso and Glad (1978) reported that the six motives for smoking 
did not predict smokers' behavior patterns in laboratory settings. 
Further, validity studies have not provided support for the 
addiction subscale. Finally, the scale has rarely been utilized 
in treatment settings. One study (Flaxman, 1979) surveyed 33 
subjects from two smoking modification studies who reported 
abstinence at follow-up. The study revealed that although the 
use of deep muscle relaxation and thought stopping were positively 
related to success, subjects did not utilize these techniques 
in relation to affect-management reasons for smoking as the 
Horn-Waingrow Scale suggests. However, this study was conducted 
after the termination of treatment. Further investigations 
are necessary in order to determine the clinical utility of the 
scale. 
Other researchers have classified smokers based on situations 
in which they smoke. For example, Best and Hakstian (1978) 
developed a 50-item situational survey from ratings of cornnon 
smoking situations. Subjects rated each of the situations on 
a scale of 1 to 7 indicating the strength of their urges to smoke 
on those occasions. The cluster analysis of the questionnaire 
resulted in a number of homogeneous factors for both sexes, e.g. 
nervous tension, self-image, frustration, relaxation, automatic. 
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and social. Differences between the sexes also emerged with males 
smoking in situations producing discomfort, inactivity, need for 
time structuring, restlessness, need for sensory stimulation, and 
need for concentration; whereas females smoked in situations 
producing uneasiness, boredom, need for food avoidance, habit, 
and need for stimulation. Best and Hakstian (1978) concluded: 
While affective factors may be important determinants of 
smoking behaviors, our cluster analyses do not suggest 
affective or any other smoker type corresponding to broad 
individual differences. Rather, the data are consistent 
with the notion that a wide variety of specific 
environmental, cognitive, affective, pharmacological, 
and sensori-motor events may serve as discriminative cues 
for smoking. Each smoker is presumably conditioned 
to many such cues, although the association is stronger 
to some cues than others, (p. 90) 
In summary, the theoretical models of smoking have resulted 
in the development of assessment devices. The Horn-Waingrow 
Scale (Ikard et al., 1969; Appendix A), which differentiates 
smokers into typologies based on self-report, and Best and 
Hakstian's situational survey (1978), which includes a broad base of 
situations in which smokers are tempted to smoke have received the 
most support from the literature. Data from both measures 
have suggested that their measures would be useful in tailoring 
smoking treatments to the needs of the individual smoker, 
although this has not been tested. 
Relapse research. The second theoretical area of importance 
in this study was process of relapse in smokers. The problem with 
high relapse rates in the treatment of smoking has been well-
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documented (Bernstein, 1969; Hunt, Barnett, & Branch, 1971; Leventhal 
& Cleary, 1980). A typical reaction to this problem has been to 
increase the initial treatment techniques, building a multimodal 
or broad spectrum treatment package. Two problems were associated 
with this approach. First, the program can become so complex 
that clients cannot comply with the procedures (Hall, 1980; 
Lando, 1981). Second, when the bulk of the treatments were 
administered prior to cessation, the focus was on the therapist's 
techniques rather than on the smokers' development of their own 
coping strategies (Marlatt, 1980). 
A different approach for treating addictive behaviors has 
been espoused by some investigators (Marlatt, 1980; Marlatt & 
Gordon, 1980). Hypothesizing that the treatment and principles 
associated with cessation and maintenance of the target behavior 
were independent (Best & Bloch, in press; Marlatt, 1980; Marlatt 
& Gordon, 1980), the focus for maintenance became the conditions 
and situations associated with relapses. In an early study. 
Hunt et al. (1971) found that approximately two-thirds of all 
the relapses occurred within 90 days after the termination 
of treatment. Traditionally, these data have been interpreted as 
supporting an addiction model. In contrast, Marlatt (Marlatt, 
1980; Marlatt & Gordon, 1980) suggested that "there may be 
common cognitive, affective, and behavioral components associated 
with the relapse process itself" (Marlatt, 1980, p. 27). 
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Marlatt and his associates (Cummings, Gordon, & Marlatt, 1980; 
Marlatt, 1980; Marlatt & Gordon, 1980) pioneered this approach to 
the study of maintenance by identifying elements common to relapse 
episodes across a variety of addictive substances (e.g., alcohol, 
smoking, drug abuse, and excessive eating). For cigarette smokers, 
Marlatt (1980) noted that over half of the relapse episodes were 
associated with stress or tension for the individual. Further, 
few relapses occurred in nonstressful situations. Cummings et 
al. (1980), in a study analyzing the relapse situations of 64 
smokers, found that 37% of the relapses were associated with 
negative emotional states; 32% of the relapses were connected 
with social pressure; and 15% of the relapses occurred during 
interpersonal conflict. These conclusions were supported by 
other investigations which found that negative affect smokers 
were at highest risk for recidivism (Pomerleau et al., 1978); 
and that negative affect, alcohol consumption, and the presence 
of other smokers were frequently cited concomitants of the 
relapse episodes (Lichtenstein, Antonuccio, & Rainwater, 
Note 9). 
In an elaborate study concerned with the relapse process, 
Shiffman (1982) established a relapse counseling hotline and 
interviewed 183 exsmokers. Shiffman (1982) presented his data for 
all of the subjects first as relapse crises, and then differentiated 
those who actually smoked from those who abstained. In detailing 
the characteristics of the relapse crises, no particular time of 
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day was most likely to result in a relapse crisis. The majority 
of the relapses occurred in the exsmokers' homes (56%), while 21% 
of the crises were at work, and 23% happened in other locations 
(e.g., restaurants, bars, etc.). The most common activities of 
the subjects included consuming food or drink (29%) and socializing 
(25%). In addition, approximately 32% of the exsmokers experienced 
relapse crises when other smokers were present. Surprisingly, 
45% of the subjects reported experiencing no withdrawal symptoms 
after quitting and only 4% of the relapse crises were associated 
with the first appearance of withdrawal symptoms. Finally, 
71% of the subjects reported experiencing negative affect prior 
to the relapse crisis, while 52% of the subjects identified 
negative affect or severe stress as the precipitant of the 
crisis. Anxiety was most often reported by the exsmokers (42%), 
followed by anger or frustration (26%) and depression (22%). 
Shiffman's study (1982) delineated situational variables 
which predicted the outcome of the relapse crises. First, 
when the subject was with another smoker, 54% of the crises 
ended in relapses, as contrasted to only 32% of the subjects 
relapsing without another smoker present. The stimulus value 
of another smoker plus the availability of a cigarette seemed to 
be powerful factors in the relapse process. These data have 
been supported by other research (Eisinger, 1971; Lichtenstein et 
al.. Note 9). Second, the rate of relapse rose from 33% to 61% in 
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situations where the exsmoker consumed alcohol. Finally, the 
site of the crisis was also a predictor with 57% of the actual 
relapses occurring in restaurants or bars, as contrasted to only 
33% happening at home or work. Although these situational 
variables distinguished the relapse crisis from the relapse 
itself, the most powerful determinant of the outcome of the 
crisis was the coping response of the exsmoker. 
Exsmokers were asked to describe any attempts to cope with 
the relapse crisis. Of the total sample, 18% of the subjects made 
no attempt to cope with the crisis, 25% coped behaviorally, 
23% coped cognitively, and 35% coped with cognitive-behavioral 
techniques. Of the exsmokers who did not attempt to cope, 
79% relapsed. The use of behavioral or cognitive coping strategies 
significantly decreased the likelihood of relapse. Further, 
71% of the subjects who used both cognitive and behavioral coping 
techniques did not relapse. This analysis demonstrated that 
active coping by the exsmoker was instrumental in preventing 
a relapse. 
Shiffman's (1982) final analysis demonstrated that exsmokers 
were less able to perform a behavioral coping response when 
they drank alcohol or experienced depression. Behavioral 
strategies were twice as effective in preventing relapse in 
nondepressed subjects. Interestingly enough, cognitive coping 
strategies were relatively unaffected by alcohol consumption and 
depression, suggesting they may be more effective in maintaining 
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abstinence. 
In summary, research concerning relapse situations demonstrated 
numerous consistencies across a number of exsmokers. Briefly, 
negative affect was correlated with the majority of relapse 
episodes (Cummings et al., 1980; Lichtenstein et al.. Note 9; 
Marlatt, 1980; Marlatt & Gordon, 1980; Pomerleau et al., 1978; 
Shiffman, 1982); and both smoking stimuli and alcohol consumption 
were frequently associated with relapse crises (Lichtenstein et 
al., Note 9; Shiffman, 1982). Researchers (Marlatt, 1980; 
Marlatt & Gordon, 1980; Shiffman, 1982) have suggested that 
focusing on the assessment of relapse précipitants for individuals 
and teaching them to cope with these situations through the 
use of cognitive and behavioral skills may be instrumental in 
preventing relapse. 
Relapse prevention model. Assuming that the maintenance of 
behavior change was associated with different factors than the 
cessation of the behavior, Marlatt and Gordon (1980) designed 
a self-control program aimed specifically at teaching individuals 
with addictive behavior problems how to anticipate and cope with 
relapse crises. Their relapse prevention model (RP) is a maintenance 
package which is implemented after an initial cessation treatment. 
The RP model applies to individuals who have made a commitment to 
abstinence, following voluntary cessation of the use of the addictive 
substance. 
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The RP model is a psycho-educational treatment which combines 
behavioral skill training with cognitive interventions. The RP 
model assumes that addictive behaviors are overlearned, maladaptive 
habits which developed by performance before or during stressful, 
unpleasant occasions. Further, addictive behaviors are strongly 
influenced by the individual's expectations associated with the 
use of the substance. 
Physiological factors play a minor role in the RP model. 
The model does not adopt the traditional requirement of abstinence 
because any use of the substance is treated as a failure and 
associated with guilt. This causes the individual to feel 
as though s/he is in complete control or total loss of control. 
Instead, Marlatt (1980) uses the term lapse to refer to a slip, 
error, or temporary use of the substance and views it as a 
learning experience rather than a failure. 
An illustration of the relapse process is presented in 
Figure 1 (Marlatt, 1980). The RP model assumes that abstaining 
individuals experience a sense of perceived control and enhanced 
self-efficacy. Self-efficacy (Bandura, 1977) is an hypothesized 
cognitive mechanism underlying behavioral change. Specifically, 
"the conviction that one can successfully execute the behavior 
required to produce the outcomes" (Bandura, 1977, p. 193) 
determines whether or not coping behaviors will be initiated and 
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sustained. The longer the period of abstinence, the greater the 
perceived control. This continues until the individual encounters 
a high-risk situation, which is "any situation that poses a threat 
to the individual's sense of control and increases the risk of 
potential relapse (Marlatt, 1980, p. 31). 
If a coping response is not performed when a high-risk 
situation is encountered, self-efficacy decreases and the use 
of the substance is likely to occur. Following the substance use, 
the individual experiences an abstinence violation effect (AVE). 
The AVE includes two cognitive-affective elements: cognitive 
dissonance (Festinger, 1964) where the individual experiences 
discomfort due to the discrepancy between the self-image as an 
abstainer and his/her use of the substance, and a personal 
attribution effect (Harvey, Ickes, & Kidd, 1976) in which the 
individual attributes the relapse to personal failure or weakness. 
The AVE varies according to several factors, including duration of 
and commitment to abstinence. The conflict and guilt resulting 
from the AVE tend to increase the probability of further relapse. 
In contrast, if an individual executes an effective coping response 
when the high-risk situation is encountered, the probability 
of relapse decreases and self-efficacy is enhanced. 
Specific interventions suggested by the RP model are depicted 
in Figure 2. In order to facilitate the use of effective coping 
responses, the RP model focuses on assessing the high-risk 
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situations and skills of each individual. The high-risk situations 
become discriminative stimuli for coping. The therapist focuses 
on teaching any necessary skills that are not within the client's 
repertoire. Since each high-risk situation cannot be identified 
in therapy, clients are also taught general problem-solving skills 
(D'Zurilla & Goldfried, 1971; Goldfried & Davison, 1973). 
In a further analysis of high-risk situations, Marlatt 
(1980) noted that relapses are sometimes planned. Upon close 
scrutiny, high-risk situations can be viewed as the last in 
a chain of events. In attempting to cope with these situations, 
individuals need to be aware of apparently irrelevant decisions 
(AIDS). These AIDs are steps which end in a high-risk situation. 
For example, when feeling frustrated or angry, an exsmoker decides 
to visit a friend with whom she used to smoke. This AID ends 
in a high-risk situation in which the individual is likely to 
relapse and she set the stage for this to happen. 
Other factors which operate in the relapse process have 
been identified. As the period of abstinence lengthens, clients 
often forget the reasons for cessation, and may begin to move 
toward a decision to resume the addictive behavior. Another 
factor operating in addictive lifestyles is the need for self-
indulgence. For example, smoking a cigarette may be the only 
relaxation that the smoker takes during the day. The RP model 
encourages clients to develop a balanced lifestyle, incorporating 
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pleasurable activities into a daily routine. 
The most unique aspect of the RP model is teaching the 
individual to cope with relapses and the AVE. The lapse (a single 
cigarette), producing guilt and discomfort, becomes a learning 
experience rather than a total failure. In some situations, 
Marlatt (1980) has even required clients to plan a programmed 
relapse in the presence of the therapist. The purpose of 
a programmed relapse is to explore the AVE and to objectively 
experience the initial return to the target behavior. By 
contrasting the expected events and feelings with the realities 
of the use, the client often becomes motivated to resume 
abstinence. For example, expectations surrounding the initial 
return to smoking are usually quite positive (e.g., relaxation, 
good taste). However, the actual sensations are often negative 
(e.g., dizziness, nausea, headache). Thus, the programmed 
relapse focuses more objectively on the experience, in contrast 
to a lapse during which the individual smokes in response to stress 
without analyzing the situation. 
Theoretical support for the RP model. Studies directly . 
testing the RP model have been limited. The relapse research 
reviewed earlier provided indirect support for the RP model 
as the investigators concluded that relapse situations were 
commonly associated with similar cognitive, affective, and 
behavioral components (Cummings et al., 1980; Lichtenstein et al.. 
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Note 9; Pomerleau et al., 1978; Shiffman, 1982). In addition, 
Shiffman's study (1982) concluded that both cognitive 
and behavioral strategies were effective at preventing relapse 
and the RP model incorporates a variety of these interventions. 
In another indirect study of the RP model, Lichtenstein 
et al. (Note 9) conducted a post hoc survey of smokers, who had 
quit and then relapsed, to test the theoretical basis of the 
AVE. They found that 61% of the relapsed smokers reported 
experiencing mild to severe guilt reactions upon resumption 
of the habit. Further, 38% of the subjects did not attempt 
to control their smoking after the first lapse. This supported 
the RP model's rejection of the traditional abstinence requirements, 
as relapsers feel guilty, assume they have lost total control, 
and pursue their habits rather than learning from the experience 
and practicing coping skills after a lapse. 
In a more controlled study, Condiotte and Lichtenstein (1981) 
investigated the relationship of relapse to self-efficacy and to the 
the AVE. Subjects were recruited from two smoking cessation programs. 
The 78 smokers provided pretreatment, posttreatment, and follow-up 
assessments of smoking rate, mood states, and self-efficacy across 
a number of situations (Best & Hakstian, 1978; Appendix B). Both 
treatment programs enhanced the self-efficacy of the participants. 
Further, the subjects' self-efficacy ratings at termination of 
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treatment predicted abstinence at the 3-month follow-up. Further, 
a high correlation emerged between the situations associated with 
relapse and those associated with low self-efficacy ratings. 
This finding suggested that subjects can predict those occasions 
which will be difficult to handle. Self-efficacy is an integral 
element of the RP model. Coping with high-risk situations enhances 
self-efficacy and promotes abstinence. Condiotte and Lichtenstein's 
findings (1981) supported the model's emphasis on enhancing self-
efficacy in order to maintain behavioral change. 
The study also investigated the AVE concept. Of the 44 
subjects who relapsed and continued smoking, 83% reported feeling 
mild to severe guilt following their first lapse. Of these 
subjects, 80% stated that this lapse exerted a moderate to severe 
negative effect on their self-confidence to abstain from smoking 
and 49% made no further coping efforts. In addition, eight subjects 
smoked at least one cigarette, but did not resume the habit. 
Of these subjects: three reported experiencing some guilt following 
the lapse, only one reported a decrease in self-efficacy, all 
of the eight subjects had self-efficacy ratings similar to 
the exsmokers who did not relapse, and all successfully controlled 
subsequent urges to smoke. These findings supported the RP model. 
Specifically, subjects who relapsed and continued to smoke experienced 
guilt and decreased self-efficacy, while subjects who relapsed 
but resumed their nonsmoking behavior experienced milder guilt 
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and maintained their self-confidence. Thus, the results of 
this study supported the importance of the self-efficacy and 
AVE constructs in the RP model. Further, Condiotte and Lichtenstein 
(1981) suggested that assessment of self-efficacy across various 
situations would be a useful tool in identifying high-risk situations 
and tailoring treatment so individuals could cope with problem 
areas. 
In a similar study, DiClemente (1981) operationalized the 
self-efficacy construct by using a 12-item situational survey 
and asking 29 male and 34 female smokers to rate their 
confidence in their ability to abstain from smoking in each 
situation. The scale involved a Likert rating system. All 
subjects had been abstinent at least 2 weeks but not more 
than 7 weeks at the time of the interview. Three different 
cessation treatments were compared (aversion, behavioral 
management, and self-quitters). Those subjects who reported 
abstinence at the 5-month follow-up had significantly higher 
self-efficacy scores than did the recidivists. Again, the 
results of this study supported the importance of the self-
efficacy construct in maintaining behavior change. 
In summary, support has been provided for the: common 
factors in relapse situations (Cummings et al., 1980; Lichtenstein 
et al.. Note 9; Pomerleau et al., 1978; Shiffman, 1982), the 
AVE (Condiotte & Lichtenstein, 1981; Lichtenstein et al.. Note 
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9), and the imporance of the self-efficacy construct in maintaining 
behavioral change (Condiotte & Lichtenstein, 1981; DiClemente, 1981). 
All of these studies endorsed the theoretical aspects of the RP 
model. To date, a few empirical investigations of the RP 
treatment have been conducted (Boelens, 1980; Brown & Lichtenstein, 
Note 10; Cooney, Kopel, & McKeon, Note 11), and these will be 
reviewed below. 
Rationale for the Present Study 
Thus far, the research delineating the theoretical models of 
smoking and relapse, and the outcome studies aimed at facilitating 
smoking cessation have been conducted independently. It is possible 
that the integration of the theoretical models, assessment devices 
and relapse prevention, and the treatment strategies would 
address two problem areas in the smoking literature. First, 
attempts to individualize treatment to the needs of the 
smoker have proven elusive5 although researchers have recognized 
the necessity of individualized treatment in the field of psychology 
(e.g., Kiesler, 1966), and more specifically, the need has been widely 
recognized within the area of smoking research (Best, 1975; Best 
& Hakstian, 1978; Best & Steffy, 1975; Coan, 1973; Costa et al., 
1980; Eysenck, 1973; Flaxman, 1979; Lando, 1980; Leventhal 
& Avis, 1976; Leventhal & Cleary, 1980; Lichtenstein & Danaher, 
1976; Pomerleau et al., 1978). 
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Although smoking cessation studies have rarely utilized 
assessment devices to individualize treatment, numerous questionnaires 
have resulted from theoretical models of smoking (Best & Hakstian, 
1978; Ikard et al., 1969). Further, the relapse prevention 
model (Marlatt, 1980; Marlatt & Gordon, 1980) was based on a 
careful assessment of the individual smoker's skills and deficits 
and treatment was designed on the basis of the individual's problem 
areas. An integration of the assessment devices with already 
existing treatment strategies may enhance the effectiveness of 
established programs, 
A second major problem in smoking research concerned the 
long-term efficacy of current treatment methods. Unfortunately, 
high recidivism rates after the termination of treatment has been 
the typical pattern. In order to increase treatment effectiveness, 
researchers have implemented multicomponent treatment packages. 
Although this approach has increased the effects of treatments 
with smokers, long-term results have still been problematic. 
Most treatments have administered the majority of the techniques 
prior to cessation of the target behavior. According to 
the RP model, the factors affecting maintenance of behavior may 
be independent of those governing cessation (Marlatt, 1980). 
Therefore, utilizing the research concerned with the relapse 
process and assessment of individual needs to tailor the treatment 
may increase the long-term efficacy of smoking clinics. 
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Preliminary work in this area will be reviewed below. 
Maintenance treatments. Four studies have compared maintenance 
treatments incorporating cognitive-behavioral interventions and 
three of these studies specifically addressed the RP model. 
First, a preliminary investigation compared cessation (aversion 
and nicotine fading) and maintenance (group support, contingency 
contracting and a structured cognitive-behavioral approach) 
(Gregory, Etringer, & Lando, Note 12). In the cognitive-
behavioral maintenance condition, a situational smoking 
questionnaire (Best & Hakstian, 1978; Appendix B) was utilized 
to tailor treatment to the individuals. Interventions included 
self-instructional training (D'Zurilla & Goldfried, 1971; 
Meichenbaum, (1977) relaxation training, thought stopping, and 
covert reinforcement. The bulk of these techniques were presented 
after the quit date. Preliminary results included 76% abstinence 
over all the groups at 2 months. This study suggested 
that tailoring treatment and using cognitive-behavioral 
interventions appears encouraging, although the study included 
only 29 subjects and needs to be replicated. 
In the second study, Boelens (1980) implemented the RP 
maintenance package in the treatment of smoking. She compared 
a multicomponent package which included contingency contracting, 
self-monitoring, and relaxation; a self-cease group which received 
no formal treatment; and a RP maintenance group which combined 
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the multicomponent interventions with the RP training. Both 
treatment groups demonstrated a sharp decrease in their smoking 
by the end of the induction phase of treatment, allowing a 
comparison of the maintenance packages. No significant differences 
emerged between the RP and the multicomponent treatment groups at 
the 6-month follow-up, although both groups reported significantly 
more abstinence than the self-cease group. Further, the self-
efficacy scores decreased from the pretreatment assessment to the 
follow-up. This finding, contrary to expectations, could have 
been due to the use of a general self-efficacy scale. Boelens 
(1980) suggested using a scale which rates self-efficacy in 
specific smoking situations in future research. 
Although Boelens' study (1980) was not supportive of the 
RP model, the results need to be interpreted with caution as 
attrition rates left the groups too small to conduct meaningful 
parametric tests (N = 6). Also, little attention was devoted to 
individualizing treatment and homework assignments. Boelens 
(1980) suggested assessing the high-risk situations earlier 
in treatment so that the maintenance interventions could be more 
closely tailored to the needs of the subject. Further, she 
stated that a more elaborate assessment protocol might prove 
useful. 
Another preliminary study (Brown and Lichtenstein, Note 10) 
incorporated identification of high-risk situations, coping 
rehearsal, the AVE, balancing one's lifestyle, and self-rewards 
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into a RP maintenance package. A clinical trial which included 
nicotine fading and self-management techniques was successful 
with a reported abstinence rate of 46% at 6 months. However, 
a controlled investigation comparing this treatment with a discussion 
control group found that abstinence rates at 3 months were only 
30% and no differences emerged between the groups. 
Finally, Cooney et al. (Note 11) recruited 118 chronic 
heavy cigarette smokers and conducted a one-session cessation 
treatment using nicotine fading and smoke holding. Following 
this, the 54 abstinent subjects received a one-session 
maintenance treatment. The first maintenance condition included 
a programmed relapse in which subjects smoked one cigarette and were 
taught how to cope with the AVE. The second condition also included a 
discussion on coping with the AVE but did not include a programmed 
relapse. The third condition involved telling the subjects that 
it was impossible to cope after smoking and they should avoid 
the first cigarette. The final condition consisted of group support. 
Subjects in the controlled relapse groups reported an immediate 
increase in self-efficacy concerning coping with slips as compared 
to the subjects in the group advocating absolute abstinence. 
However, over a 24-week follow-up, subjects in the controTled relapse 
conditions tended to relapse earlier than those in the absolute 
abstinence condition. The authors concluded "There appears to 
be a paradox that controlled relapse treatment led to increased 
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self-efficacy but earlier relapse relative to absolute abstinence 
treatment" (Cooney et al., Note 11, p, 1). The authors further 
suggested the timing of the programmed relapse may be crucial 
as subjects in the controlled relapse groups may have a false 
confidence in their ability to smoke a cigarette and then quit. 
Finally, self-efficacy ratings were not predictive of outcome 
in this study. 
The four studies comparing maintenance treatments and 
using the RP protocol were not definitive. First, the 
cessation techniques varied. Boelens (1980) used only a 
contingency contracting procedure, Gregory et al. (Note 12) 
compared satiation and nicotine fading. Brown and Lichtenstein 
(Note 10) used only nicotine fading, and Cooney et al. (Note 
11) implemented a one session treatment using smoke-holding 
(Kopel et al.. Note 6). Although the fading and aversion 
techniques have received empirical support (Foxx & Brown, 1979; 
Lando & McCullough, 1978), it was unclear which technique 
would be best to combine with a structured maintenance package. 
Second, none of the studies conducted elaborate assessment 
of the smoker's needs to facilitate individualizing treatment. 
Third, the RP protocol was used only in two studies. In 
Boelens' (1980) study, the small sample size precluded meaningful 
conclusions concerning the treatment. Brown and Lichtenstein's 
research (Note 10) conflicted, with a positive outcome in a 
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clinical trials evaluation and no significant effects for the RP 
treatment in the controlled study. This merits replication. 
The one-session maintenance concerning the AVE in Cooney 
•et al.'s study (Note 11) did not include the .entire RP 
treatment and so conclusions from this study are difficult. 
Finally, self-efficacy was measured only by Boelens (1980) 
and Cooney et al. (Note 11). Boelens used a global measure 
of self-efficacy and Cooney et al. asked subjects for a confidence 
rating that they would immediately return to abstinence after 
a lapse. Both of these measures were inadequate to assess 
the subjects' self-efficacy about smoking in a variety of 
situations. Clearly, however, these studies have provided the basis 
for further research in the area of RP treatment, including 
assessment of needs and individualizing therapy and measuring 
changes in self-efficacy. 
The present study. The present study incorporated both 
the theoretical and empirical advances in the field of smoking 
into a comprehensive treatment package. The study was a 
2 (cessation) x 2 (maintenance) design. The two cessation 
techniques were the satiation procedure, originally described 
by Resnick (1968) and refined by Lando (1977), and the nicotine 
fading procedure (Foxx & Brown, 1979). The two maintenance 
packages were a group support/contingency contracting treatment 
(Lando, 1976c), which has proven effective in several clinical 
43 
trials when combined with the satiation procedure (Lando, 1977; 
Lando & McCullough, 1978), and a RP protocol focusing on the relapse 
process and cognitive-behavioral skills training. 
The RP maintenance package included an elaborate assessment 
battery (Horn & Waingrow, Note 8, Appendix A; Joffe et al., 1981, 
Appendix L) for tailoring treatment to the needs of the individual 
smoker. In addition, smokers were asked to identify their own 
high-risk situations and were taught a variety of cognitive-
behavioral coping strategies to facilitate not smoking. Also, 
the treatment focused on preventing relapse through the 
presentation of relapse information and the use of the RP protocol 
(Marlatt, 1980; Marlatt & Gordon, 1980). Further, the study 
investigated the relationship of numerous variablés to outcome. 
Specifically, self-efficacy, adherence to treatment interventions, 
attendance, and group cohesion were assessed. Finally, 
subjects were interviewed concerning the processes and situations 
surrounding relapses (Appendix W). 
The following hypotheses were investigated. First, subjects 
in the RP group were expected to evidence a significantly higher 
long-term success rate than those in the group support/contingency 
contracting maintenance. Second, adherence to interventions 
(attendance, self-monitoring) was hypothesized to relate to 
successful outcome. Third, subjects in the RP group were 
expected to exhibit significantly higher self-efficacy scores than 
those in the group support/contingency contracting group. 
44 
Fourth, abstainers were anticipated to report significantly 
higher self-efficacy levels than those who relapsed. Finally, 
no prediction was made concerning the differential effectiveness 
of the nicotine fading and satiation cessation techniques. 
However, it was hoped that the nicotine fading plus the RP 
maintenance would be as effective as the satiation procedure. 
To date, the nicotine fading treatment has not been clearly 
established as equal to the aversion in effectiveness. If indeed 
the nicotine fading was proven as effective as the aversion 
treatment, the applicability of the smoking cessation treatment 
would be generalized to all smokers regardless of health 
concerns. 
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METHOD 
Overview of the Study 
Subjects 
Eighty-eight subjects were recruited from the Salt Lake 
City metropolitan area and the University of Utah. Recruitment 
procedures included posters, advertisements in local newspapers, 
public service announcements, and letters to businesses and 
church organizations (Appendix C). Any smoker who wanted to 
quit was eligible for this program upon meeting a few additional 
criteria. First, subjects were required to pay a $10 fee for 
the program plus a $10 refundable deposit which was designed to 
encourage the returning of follow-up data. Second, subjects 
were required to complete an informed consent form (Appendix D) 
and a medical consent form (Appendix E). The latter form 
was completed by the smoker's physician and contained an explanation 
of the program and potential medical risks. Subjects with serious 
health problems or who were unable to obtain the physician's 
approval were assigned to the nicotine fading procedure and 
their data were eliminated from the analysis. 
Of the 88 subjects presenting themselves for treatment, 
nine were eliminated. Five of the subjects were considered 
drop-outs, as they attended two or fewer sessions. Four of 
the subjects were treated with the nicotine fading procedure 
but were deleted from the analysis because their health 
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problems precluded random assignments to the treatments. The 
characteristics of the remaining 79 subjects are presented in 
Table 1. 
Therapists 
The therapists, one female and one male, were both 
experienced at conducting stop-smoking clinics. The author 
had worked in this field for 5 years, while the other therapist 
had 3 years of experience. Both were advanced doctoral students 
with expertise in cognitive-behavioral interventions and 
extensive familiarity with the smoking literature. The initial 
data analyses included therapist as a factor. 
Setting 
The study was conducted through the counseling center at 
the University of Utah. Classroom space was provided at 
the University for holding the group meetings. 
Design 
The initial experimental design was a 2 x 2 x 2 factorial in 
which the factors included treatment (satiation vs. nicotine 
fading), maintenance (unstructured group support plus contingency 
contracting vs. cognitive-behavioral relapse prevention), and 
therapists. As no therapist effects were evidenced on the 
smoking outcome measures, this factor was dropped from the analysis 
leaving a 2 x 2 factorial. Subjects were assigned to treatment 
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Table 1 
Subject Characteristics 
Maintenance Relapse Prevention 
Satiation Fading Satiation Fading 
Males 9 8 7 13 
Females 9 11 11 11 
Average Age 35.6 33.4 40.4 42.2 
Average Years 
Smoking 17.5 16.9 20.6 22.4 
Average Baseline 
Smoking Rate 29.9 27.7 26.8 25.8 
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groups on a random basis. As previously noted, the only exception 
to this was smokers with serious health concerns. These smokers 
were assigned to the nicotine fading treatments and excluded from 
the data analysis. 
Procedure 
Treatment was conducted in small groups of eight to 12 members. 
Each therapist conducted four treatment groups: nicotine fading 
plus group support and contingency contracting (e.g., Lando, 1977) 
(NF + M), aversion plus group support and contingency contracting 
(AV + M), nicotine fading plus a cognitive-behavioral relapse 
prevention package (NF + RP), and aversion plus a cognitive-
behavioral relapse prevention package (AV + RP). 
The entire treatment package occurred over a 10-week 
period. The first three weeks were devoted to the cessation 
techniques (nicotine fading and aversion). The remaining seven 
weeks constituted the different maintenance treatments. Table 
2 delineates the timing of the sessions and the interventions and 
measures administered at each meeting. Subjects met on a weekly 
basis for approximately 60 to 90 minutes. The exceptions to 
this schedule occurred during the third and fourth weeks of 
treatment. At this time, subjects met for six consecutive week-
nights. The sixth meeting was the quit date. The experimental 
conditions (NF + RP and AV + RP) did not differ from the 
established treatment formats (NF + M and AV + M) until the third 
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Table 2 
Summary of Interventions 
Orientation 
Overview and rationale of treatment 
Measures 
Week 1, Session 1: Cessation Treatment 
NF Groups 
Introductions 
Treatment rationale 
Explain self-monitoring 
30% reduction assignments 
Week 2, Session 2 
NF Groups 
Open discussion 
Review adherence 
60% reduction assignments 
Week 3, Session 3 
NF Groups 
Open discussion 
Review adherence 
Physiological information 
90% reduction assignments 
Week 3, Session 4 
AV Groups 
Introductions 
Treatment rationale 
Explain self-monitoring 
AV Groups 
No meeting 
AV Groups 
Open discussion 
25 minutes of intensive 
smoking 
Physiological information 
NF + M 
Open discussion 
Overview of maintenance 
AV + M 
Open discussion 
25 minutes of intensive 
smoking 
Overview of maintenance 
NF + RP 
Open discussion 
Overview of maintenance 
Identify and discuss 4 
high-risk situations 
AV + RP 
Open discussion 
25 minutes of intensive 
smoking 
Overview of maintenance 
Identify and discuss 4 
high-risk situations 
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Table 2 (Continued) 
Week 3, Session 5 
NF Groups AV + M 
No meeting Open discussion 
25 minutes of intensive 
smoking 
AV + RP 
Open discussion 
25 minutes of intensive 
smoking 
Share commonalities of 
4 high-risk situations 
Introduce self-instructional 
training 
Week 3, Session 6 
NF + M 
Open discussion 
Focus on feelings surrounding 
quitting smoking 
NF + RP 
Open discussion 
Share commonalities of 4 
high-risk situations 
Introduce self-instructional 
training 
Review rationalizations 
handout 
Introduce problem-solving 
Week 3, Session 7 
NF + M 
Open discussion 
Focus on feelings surrounding 
quitting smoking 
Review important suggestions 
AV + M 
Open discussion 
Focus on feelings surrounding 
quitting smoking 
25 minutes of intensive 
smoking 
AV + RP 
Open discussion 
25 minutes of intensive 
smoking 
Review self-instructional 
training 
Review rationalizations 
handout 
Introduce problem-solving 
AV + M 
Open discussion 
Focus on feelings surrounding 
quitting smoking 
Review important suggestions 
25 minutes of intensive 
smoking 
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Table 2 (Continued) 
NF + RP 
Open discussion 
Review problem-solving task 
Focus on feelings surrounding 
quitting smoking 
Week 4, Session 8: Quit Date 
NF + M 
Discussion focuses on quitting 
Quit and discard cigarettes 
Contingency contracts 
Confidence questionnaire 
NF + RP 
Discussion focuses on quitting 
Quit and discard cigarettes 
Review coping strategies 
Sign contract to limit use 
Confidence questionnaire 
Week 4, Session 9: Maintenance Treatment 
M Groups 
Review successes 
Troubleshoot problems 
Contingency contracts 
Week 5> Session 10 
M Groups 
Open discussion 
Review successes 
Troubleshoot problems 
Contingency contracts 
Collect 1 week follow-up 
AV + RP 
Open discussion 
25 minutes of intensive 
smoking 
Review problem-solving 
task 
Focus on feelings surrounding 
quitting smoking 
AV + M 
25 minutes of intensive 
smoking 
Discussion focuses on quitting 
Quit and discard cigarettes 
Contingency contracts 
Confidence questionnaire 
AV + RP 
25 minutes of intensive 
smoking 
Discussion focuses on quitting 
Quit and discard cigarettes 
Review coping strategies 
Sign contract to limit use 
Confidence questionnaire 
RP Groups 
Review successes 
Review coping strategies 
Introduce urges material 
Discussion focuses on urges 
worksheet 
RP Groups 
Open discussion 
Review successes 
Review coping strategies 
Game plans 
Collect 1 week follow-up 
I 
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Table 2 (Continued) 
Week 6, Session 11 
M Groups 
Open discussion 
Review successes 
Troubleshoot problems 
Contingency contracts 
Week 7, Session 12 
M Groups 
Open discussion 
Review successes 
Troubleshoot problems 
Contingency contracts 
Week 8, Session 13 
M Groups 
Open discussion 
Review successes 
Troubleshoot problems 
Contingency contracts 
Collect 1 month follow-up 
Week 9, Session 14 
M Groups 
Open discussion 
Review successes 
Troubleshoot problems 
Contingency contracts 
Week 10, Session 15 
M Groups 
Open discussion 
Review successes 
Troubleshoot problems 
Closure of the group 
Confidence questionnaire 
Group cohesion measure 
RP Groups 
Open discussion 
Summarize relapse information 
Review coping strategies 
Introduce AIDS 
RP Groups 
Open discussion 
Relapse fantasy 
Discuss AVE and self-efficacy 
Review coping strategies 
RP Groups 
Open discussion 
Review successes 
Review coping strategies 
Troubleshoot problems 
Collect 1 month follow-up 
RP Groups 
Open discussion 
Introduce positive addictions 
Discuss want/should ratio 
Review strategies 
Troubleshoot problems 
RP Groups 
Open discussion 
Review successes 
Troubleshoot problems 
Closure of the group 
Confidence questionnaire 
Group cohesion measure 
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week of treatment except for utilizing different self-monitoring 
techniques. The maintenance packages for the experimental and 
established treatment conditions were very different. An outline 
listing the specific interventions employed in the various groups 
is presented in Table 2. 
Orientation. The experimenters explained that smoking is 
an overlearned habit. The leaders briefly described the satiation 
and nicotine fading procedures and provided an overview of the 
treatment package. Throughout the orientation and treatment sessions, 
the leaders emphasized the necessity of the smokers' determination to 
quit smoking. This determination was essential to the success of the 
treatment as no magic cures exist. The leaders also stressed the 
importance of active participation in the groups, attendance, group 
support, and implementation of the treatment techniques. 
As this was a research project, the leaders explained the 
necessity of random assignment to treatment groups. Exceptions included 
the four smokers with health problems who were assigned to the nicotine 
fading treatments. The subjects were required to complete a number of 
questionnaires before the next meeting, including the: Horn-Waingrow 
scale (Appendix A), the confidence questionnaire (Appendix B), the 
informed consent form (Appendix D), the medical consent form (Appendix 
E), and the smoking history questionnaire (Appendix F). Finally, 
smokers were asked to pay a $10 fee and a $10 deposit, the latter to be 
refunded after the 6-month follow-up data.were returned to the 
experimenter. 
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Treatment Packages 
Cessation techniques 
Nicotine fading. The rationale for the nicotine fading procedure 
was based on minimizing the withdrawal symptoms from nicotine as 
most of the nicotine had been withdrawn from the subjects' systems 
prior to the quit date due to the changing of brands (Foxx & Brown, 1979). 
Further, the subjects' ability to adhere to changing brands may have helped 
insure the success of the groups. Also, some smokers have noticed 
an increase in positive health signs as they changed brands, providing 
further reinforcement of success expectations. Finally, the procedure was 
nonaversive and applicable to all smokers regardless of health problems. 
In the nicotine fading procedure, smokers changed their brands of 
cigarettes to other brands with lower levels of nicotine over a three week 
period. The decisions regarding brand changes were made by referring to 
the latest Federal Trade Commission (FTC) listing (Appendix G). The 
first week, smokers decreased the nicotine content of their baseline 
brand by 30%. Subsequent reductions from baseline brand were 60% and 90%. 
These changes were made during weeks two and three, respectively. At 
the end of the third week, smokers quit smoking. 
Aversion. The rationale for the intensive smoking group was based 
on the concept of aversion. The therapists explained that many smokers 
attempted to break the habit by decreasing the number of cigarettes 
they smoked. In contrast to the anticipated result, the cigarettes 
smoked became more reinforcing and it was more difficult to quit 
smoking. The intensive smoking treatment required the smoker to attempt 
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to double his/her baseline smoking rate which decreased the reinforce­
ment value of the cigarettes and made it easier to quit. The subjects 
were specifically encouraged to smoke when they did not want a cigarette. 
Further, they participated in six clinic sessions during which they 
engaged in 25-minutes of continuous smoking without participating 
in any distracting activities. The groups met in small rooms to 
maximize the aversiveness. The purpose of this technique was to assist 
smokers in focusing their attention on the lack of pleasure derived from 
pure smoking in the absence of outside stimulation. Subjects were 
instructed to discontinue smoking in the event of dizziness, nausea, 
or feeling ill both during the 25-minute sessions and in general. The 
purpose in intensive smoking was not to smoke to the point of illness. 
Finally, subjects were strongly encouraged to complete the entire week 
of intensive smoking to maximize the benefits of this intervention. 
Common treatment elements. Although the cessation treatments were 
entirely different, the groups had some similar experiences and 
assignments. First, the groups were conducted informally with emphasis 
on open discussion and group support. Second, all groups were 
required to self-monitor their smoking behavior throughout the cessation 
treatment. Pocket-sized booklets were provided for this purpose. The 
booklets were blocked off into 15-minute time intervals for easy 
recording. Subjects were requested to record each cigarette smoked. 
These data resulted in the establishment of a baseline smoking rate. 
Finally, all groups received a presentation informing them of the, 
physiological aspects of smoking (Appendix H). This information was 
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presented in nontechnical language and was not intended.as a scare tactic. 
Maintenance treatments 
The M package. This maintenance package has been proven effective 
in several investigations (e.g., Lando, 1977; Lando & McCullough, 
1978). The treatment focused on unstructured group support plus 
contingency management as described by Lando (1976c). This 
maintenance treatment began during the third week with the presenta­
tion of an overview of the interventions following the quit date. 
In addition, a list of important suggestions for quitting (Appendix 
I) was presented and discussed during the third week of treatment. 
The discussion focused on generating alternatives to smoking 
and troubleshooting problem areas that the individuals presented. 
No cognitive-behavioral skills were taught to these groups. 
During the maintenance phase of treatment, therapists 
encouraged and faciliated group discussion. The groups were 
conducted in an unstructured manner. Subjects discussed their 
successes at maintaining abstinence and their problems with relapse. 
These topics were reviewed on a weekly basis. Group members were 
encouraged to support each other and to assist in generating ideas 
that facilitated abstinence. 
In addition to the group support and discussion, subjects 
completed contingency contracts (Appendix J) and self-management 
contracts (Appendix K). The contingency contracts covered the 
time interval between meetings and consisted of rewards for not 
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smoking and punishments for smoking. Subjects chose their own rewards 
and punishments and were encouraged to adhere to their contracts. 
Therapists stressed that rewards for not smoking were particularly 
important to enjoying life without cigarettes. Similarly, the 
punishments were intended to assist subjects in resisting urges to smoke. 
The self-management contracts covered a one month period. This 
contract required subjects to pay a specified amount of money per 
cigarette smoked to an organization of their choice. Both the 
organization and the amount of money were determined by the subjects. 
The therapists informed the subjects that the contracts were intended 
to be a deterrent to smoking, yet realistic so that the subjects 
would indeed forfeit the money if they smoked. 
The RP package. Although this was a more structured maintenance 
package, therapists encouraged open discussion during the sessions. 
The material was presented in a relaxed atmosphere with emphasis on 
group participation to maximize the effectiveness of the interventions. 
In addition, the written work, which was minimal, was completed during 
the meetings to increase adherence to the procedures. The written 
assignments were also integrated into the group discussions. Generally, 
the groups were approximately 60 to 90 minutes in length. 
This maintenance package also overlapped with the cessation 
procedures. Subjects assigned to these groups had an additional 
self-monitoring assignment to facilitate the tailoring of 
treatment to their individual needs. Specifically, subjects 
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were asked to list the reasons that they smoked each cigarette 
during a three hour period each day. This time period was 
identified by red ink in their recording booklets. The time 
periods assigned across the different days were: 6:00 a.m. to 
9:00 a.m., 9:00 a.m. to 12:00 p.m., 12:00 p.m. to 3:00 p.m., 
3:00 p.m. to 6:00 p.m., 6:00 p.m. to 9:00 p.m., and 9:00 p.m. 
to 12:00 a.m. Subjects were asked to list the reasons on the 
back pages of their booklets. The reasons were categorized 
into the following classifications: S = stimulation, M = 
manipulation, N = negative affect reduction, A = addiction, 
PR = pleasurable relaxation, and H = habit. A description 
of each of these categories was given to the subjects (Appendix 
L). This procedure was developed by Joffe et al. (1981). 
The rationale for utilizing this intervention involved the 
identification of high-risk situations for each individual which 
would facilitate the tailoring of the treatment components. 
During the third week of treatment, subjects were asked to 
identify four situations which they considered to be high-
risk occasions for smoking. This was another part of the 
assessment procedure. Group discussion focused on the common 
and unique problem areas for the individual group members. 
The therapist provided feedback on the assessment devices 
(the Horn-Waingrow scales, the self-monitoring tasks, and 
the four high risk situations) to stimulate discussion in 
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in the group and to tailor the treatments that were later 
presented. 
The therapist also introduced a self-instructional training 
approach (Meichenbaum, 1977). This was presented in two steps. 
First, group members needed to identify self-statements which 
encouraged smoking. In order to facilitate this, the rationaliza­
tions handout (Appendix M) was discussed. Subjects were encouraged 
to add their own "smoke talk" to the list. Second, it was 
necessary for the smokers to substitute positive coping statements 
(Appendix N) for negative statements. 
The next intervention was the problem-solving approach 
(D'Zurilla & Goldfried, 1971). The outline for this presentation 
is in Appendix 0. Briefly, the therapists provided the format 
and facilitated group discussion which focused on generating 
alternative situations to smoking. Subjects were assigned to 
write analyses of their own high-risk situations and to identify 
alternatives to smoking. 
On quit night, the discussion focused on the subjects' 
feelings about quitting. In addition, the coping strategies 
were reviewed. Subjects were required to sign a contract to limit 
use of cigarettes (Appendix P). The therapists stressed that 
future smoking behavior should be viewed as a lapse and 
result in a learning experience rather than a failure. The 
purpose of this contract was to assist individuals in coping with 
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urges to smoke and to restrict any smoking behavior to a lapse. 
Further, the therapists stressed that this was not permission 
to smoke or an invitation to resume smoking. Instead, it was 
described as realistic to consider the possibility of smoking. 
Many individuals feel that if they smoke a single cigarette, 
they are doomed to return to the habit as they are weak 
people. This maintenance approach was designed to avoid such 
thinking and to teach people how to prevent their own relapses. 
Early in the maintenance phase of treatment, the therapists 
introduced and discussed the concept of urges (Salt Lake Veteran's 
Administration, Note 13; Taylor & Lantinga, Note 14; Appendix 
Q). Group members were encouraged to participate in the 
discussion, resulting in the subjects' analyses of their 
own urges to smoke. The therapists stressed the importance of 
identifying and understanding the cognitions, emotions, and 
situations accompanying urges. In addition, subjects listed the 
short-term benefits of smoking versus the long-term consequences. 
It was emphasized that this analysis was important to recall during 
times when the subjects experienced urges to smoke. Finally, 
the therapists accentuated the idea that individuals who actively 
cope with urges do not smoke, whereas those who do not cope are 
more likely to return to the habit. 
Following the urges material, the subjects developed 
game plans (Salt Lake Veteran's Administration, Note 13; Appendix 
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R) to cope with their urges in high-risk situations. This 
material incorporated the self-instructional and problem-solving 
techniques introduced earlier with the urges lecture. The work­
sheets were completed during the session and provided the 
basis for discussion (Appendix Q). Thus, subjects received 
extended practice in the use of cognitive-behavioral 
coping skills aimed at not smoking. 
During the maintenance phase of treatment, therapists 
concentrated more specifically on the RP model (Marlatt, 1980). 
They presented a summary of the relapse research, focusing 
on situations in which relapses were common. Also, they emphasized 
that active coping with urges decreases the rate of relapse. 
Figure 1 (p. 28) was utilized to present an overview of the RP model. 
Again, therapists described smoking behavior as a lapse and 
stressed that it could be used as a learning experience. 
A further extension of the self-instructional and problem-
solving techniques included the introduction of the concept of 
AIDS. Therapists emphasized that relapses were often planned 
by a series of apparently irrelevant decisions (AIDS). Discussion 
focused on analyzing the thoughts and decisions that led to 
high-risk situations. These decisions were described as cues to 
begin coping techniques learned previously. 
It should be noted that the timing of the interventions 
was flexible to meet the individual's needs. For example, 
an analysis of what occurs in the event of a relapse is a central 
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concept in the RP model. This topic was covered when group 
members began to report relapsing. In addition, therapists 
utilized guided imagery in structuring relapse fantasies for 
the group members. This served as a stimulus for discussion 
of expectations surrounding smoking. For example, one 
individual may expect instant relaxation, while another may 
expect to deal with crisis situations more effectively. 
Instead of the anticipated results of smoking, therapists 
focused on the realistic consequences. Specifically, the 
cigarettes often did not provide the desired effects. This 
discussion led into the introduction of the AVE which includes 
both cognitive dissonance (Festinger, 1964) and a personal 
attribution effect (Harvey et al., 1976). The therapists 
also emphasized the relationship of the AVE to the individual's 
self-efficacy (Bandura, 1977). To facilitate and clarify 
the AVE, a worksheet was completed and discussed in the group 
(Appendix S). 
The final concepts the therapists introduced in this maintenance 
package focused on the development of a healthier, more enjoyable 
lifestyle. Many exsmokers have returned to the habit because 
smoking was one of the few relaxing, pleasant activities in 
which they engaged. Therapists stressed that in order to 
stop smoking it was frequently necessary to make other life 
changes. Specifically, group discussion focused on the development 
of positive addictions (Glasser, 1976; Appendix T) to replace 
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smoking. To facilitate an analysis of one's lifestyle, the therapists 
explained the ratio of wants and sMoulds. Many individuals are 
busy doing everything they should during their time, while they 
make little time available to experience some of the pleasures in 
life (the wants). Discussion focused on the development of 
a balanced lifestyle by monitoring the want/should ratio (Appendix 
U). 
Measures 
Assessment measures 
Although subjects in all groups completed the Horn-Waingrow 
scale (Horn & Waingrow, Note 8; A"ppèhdix A), it was used for 
tailoring treatment only in the RP groups. This was a 23-item 
inventory which required smokers to rank their motives for 
smoking on a 5-point scale (1 = never, 2 = seldom, 3 = occasionally, 
4 = frequently, and 5 = always). The scale classified the smokers' 
motives for smoking into the following categories: reduction of 
negative affect (6 items, score of 21 or more was high), addiction 
(5 items, score of 17.5 or more was high); habitual (4 items, score 
of 14 or more was high); stimulation (3 items, score of 10.5 or 
more was high), sensori-motor manipulation (3 items, score of 
10.5 or more was high), and pleasurable relaxation (2 items, score 
of 7 or more was high). 
Categories in which subjects received high scores highlighted 
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their motives for smoking. Consequently, concentrating on these 
areas in the RP group facilitated the individualization of 
treatment. For example, if a subject scored high on the reduction 
of negative affect scale, the therapist focused on teaching 
skills for the management of negative affective states. The 
subjects in the groups reported more similarities than 
discrepancies, facilitating the presentation of information 
tailored to specific problems. 
Dependent measures 
Subjects in all groups monitored their smoking rates during 
the cessation treatments. These data were used to establish 
base rates of smoking and to check on the adherence to the 
treatment in the AV groups. After the quit date, subjects 
continued to monitor and report their smoking rates. Data 
were collected concerning abstinence versus smoking, percentage 
of baseline smoking rates, and brand of cigarettes smoked. 
In addition, smokers provided the names of three people whom the 
experimenters could contact to verify the subjects' self-reports. 
The confidence questionnaire (Condiotte & Lichtenstein, 1981; 
Appendix B) served as the measure of self-efficacy. It was 
administered to all the subjects. It consisted of 49 situations 
in which people smoke. Subjects were required to rate their 
confidence levels in each situation by using a scale of 0 to 
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100 with 0 = certain failure and 100 = complete confidence they 
could refrain from smoking. Analyses of the subscales imbedded 
within the confidence questionnaire (Condiotte & Lichtenstein, 1981) 
have resulted in the delineation of 8 subscales: restlessness 
(12 items), intrapersonal negative mood (11 items), crutch (9 items), 
time structuring (4 items), automatic (4 items), interpersonal 
negative mood (3 items), self-image (3 items), and social (3 
i tems). 
Nine separate scores were calculated from this scale. 
First, an overall measure of self-efficacy as related to smoking 
was obtained by averaging across the 49 items. Mean scores 
were also calculated on the remaining scales. This procedure was 
developed by Condiotte and Lichtenstein (1981). This measure 
was administered before treatment, on the quit date, and at the 
termination of treatment. 
Other dependent measures included the group cohesion 
questionnaire (Appendix V) and attendance. The group cohesion 
questionnaire consisted of 10 items concerning the group 
atmosphere. Subjects rated each item on a Likert-scale of 
1 to 7. The questionnaire was administered at the termination of 
the treatment groups. In addition, attendance was used as both 
a measure of cohesion and adherence to the treatment. Attendance 
has previously been used to measure group cohesion (Etringer et al.. 
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Note 7). Further, most of the assignments were completed during the 
sessions, and so attendance was also a measure of adherence to the 
treatment. 
Follow-up interviews 
Smoking rate data (both abstinence and percentage reduction 
from baseline) were collected at 1 week, 1 month, 3 months, and 
6 months after quit date. Subjects were initially contacted 
by mail and then by telephone to determine their smoking status. 
In addition, informants were asked to verify the smokers' self-
reports. Approximately one-half of the informants were selected 
at random and contacted. Only two informants contradicted the 
subjects' self-reports and in both instances, the subjects 
reported smoking and the informants stated that the subjects 
were abstinent. Thus, the self-reports of the subjects appeared 
to be reliable. 
Subjects who reported smoking at any time during the 
follow-up period were subsequently telephoned and interviewed 
concerning the circumstances surrounding their relapses (Appendix 
W). Of the 46 subjects who had relapsed by the 6 month 
fo l low-up date ,  31 completed re lapse in terv iews (67%) .  
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RESULTS 
Preliminary Analyses 
Subjects 
Subject characteristics are listed in Table 1 (p. 47). 
Forty-one of the subjects were females, while 38 were males. 
The mean age for the subjects was 38.17, the mean for the number 
of years smoking was 19.56, and the mean baseline rate was 27.42 
cigarettes per day. Analyses of variance indicated no significant 
differences among the groups for number of years smoking, baseline 
smoking rate, or self-efficacy (Condiotte & Lichtenstein, 1981) 
on the first administration. However, analysis of variance 
for age of subjects indicated that a significant difference existed 
between standard M and RP subjects, F (1, 72) = 4.89, p <..05. 
The breakdown of age across various groups revealed that subjects 
in the AV-M and NF-M groups were younger than those in the AV-RP 
and NF-RP groups. 
Adherence 
Subjects in the satiation groups increased their smoking 
during the week of intensive smoking to 156% of their baseline 
rates. This indicated good adherence to the satiation groups. 
This degree of adherence was comparable to that found in other 
studies utilizing the intensive smoking format (Lando, 1977, 1980). 
In the NF groups, all subjects reported smoking the lower nicotine 
brands they had been assigned. Weekly discussions indicated some 
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subjects occasionally smoked a higher nicotine cigarette, but this 
behavior was relatively infrequent. 
Attendance was generally excellent, with an overall average of 
three absences per subject. However, an analysis of variance 
indicated a significant difference for the number of absences as 
a function of the maintenance treatment, F (1, 63) = 12.74, p<^.001. 
The total number of absences for the AV-M and NF-M groups 
equalled 157, with a mean of 4.24 absences per subject. In contrast, 
the total number of absences for the AV-RP and NF-RP groups equalled 
only 92, with a mean of 2.19 absences per subject. This could 
have been due, in part, to the variety of new discussion topics 
in the RP groups. 
In addition, the difference could have been caused by the 
different philosophies of the maintenance treatments concerning 
relapse. Specifically, the therapists in the RP groups viewed 
smoking a cigarette as a lapse and a learning experience, while 
they promoted the view of total abstinence in the M groups. Subjects 
in the M groups who did not relapse missed a mean number of 2.16 
sessions after the quit date, while subjects in the RP groups 
who did not relapse missed only an average of 1.04 sessions. 
Perhaps more interesting is the finding that relapsers in the M 
groups missed an average of 4.83 sessions after the quit date, 
as contrasted to relapsers in the RP groups who missed only an 
average of 2.43 sessions during the maintenance treatment. Thus, 
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subjects who relapsed in the M groups missed twice as many sessions 
during the maintenance phase of treatment as reTapsers in the 
RP groups. 
Generally, subjects adhered to assignments made in the groups. 
Assignments in the RP groups were completed during the sessions 
so the excellent attendance rate indicated compliance with the 
requirements. In the AV-M and NF-M groups, subjects lost interest 
in the contingency contracts after approximately 2 weeks and in 
most cases, these were discontinued. The therapists did encounter 
resistance in the RP groups to the discussion of relapse fantasies 
and completing the AVE assignment. Subjects interpreted these 
exercises as the therapists' lack of confidence in the group 
members' ability to abstain from smoking. 
Smoking Assessment 
Percentage reduction analyses 
A split-plot analysis of variance was utilized to test for 
the between-group differences in percentage reduction from 
baseline smoking rate over the four follow-up periods (1 week, 
1 month, 3 months, and 6 months). The percentage reductions 
from baseline smoking levels are depicted in Table 3. No 
main effects or interactions were obtained as a function of the 
cessation treatments (AV and NF), although the combined percentage 
reduction scores indicated that the NF groups evidenced slightly 
higher percentage reduction rates from the 1 month through the 
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Table 3 
Percentage Reductions from Baseline Smoking Levels 
Group Week 1 Month 1 Month 3 Month 6 
NF-M 91 .57 82 .55 53, .90 39 .60 
AV-M 96, .98 81 .36 61. ,67 49 .21 
NF-RP 94, .46 77 .88 74. ,12 64 .75 
AV-RP 100, ,00 71, .16 63. 01 48, .29 
Combined M Groups 94. ,21 81, .97 57. 68 44, .28 
Combined RP Groups 96. ,83 75. ,00 69. 36 57. ,70 
Combined AV Groups 98. ,49 76. ,26 62. 34 48. ,75 
Combined NF Groups 93. 18 79. 94 65. 19 53. 64 
All Groups 95. 60 78. 27 63. 89 51. 41 
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6 month follow-up periods. Also, .although no significant differences 
emerged between the maintenance groups (M and RP), the RP groups 
reported higher percentage reduction rates at both 3 and 6 month 
follow-ups. No differences emerged between the therapists. 
No main effects were found for the maintenance intervention. 
However, a significant difference was evidenced for the maintenance 
by time interaction, F (1, 71) = 2.93, p<.05. Comparing the 
percentage reduction rates for the different maintenance treatments, 
the RP groups relapsed at a slower rate over follow-up than the 
M groups. In addition, a highly significant time effect was found, 
F (1, 71) = 49.42, p<.001, indicating that all of the groups 
increased their smoking rates over the follow-up periods. Despite 
this increase in smoking over time, it should be noted that the 
percentage reduction for all the groups combined at the 6-month 
follow-up was still 51.41%. 
Abstinence 
The second measure of smoking was abstinence. These data 
provide a more stringent and clinically meaningful outcome measure 
of the smoking treatment's efficacy. In addition, abstinence was 
the goal of the subjects in the present study. It was an exact 
criterion and was not subject to inaccuracies in the subject's 
self-monitoring as was the percentage reduction measure. Percent 
of subjects abstinent by group and by combined maintenance treatments 
(M and RP) and cessation treatments (AV and NF) are presented in 
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in Table 4. 
Chi-square analyses on this dichotomous variable indicated 
a significant difference between the cessation treatments 
with the AV groups reporting initially higher abstinence rates 
than the NF groups at week 1. However, this difference favoring 
the AV cessation treatment was no longer evident at 1 month follow-up. 
No significant differences emerged between the maintenance treatments. 
The chi-square figures for the cessation treatments were: at 
1 week = 3.93, p<.05, at 1 month 1^(1) = .28, at 3 months 
%2(1) = .004, and at 6 months 7C^(1) = .06. The chi-square 
figures for the maintenance treatments were: at 1 week %^{l) = .008, 
at 1 month %?-{\) = .37, at 3 months X^(l) = 1.45, and at 6 
months = i,27. Finally, the overall chi-square figures were: 
at 1 week ^^(3) = 4.24, at 1 month X?[3) = .85, at 3 months /^(3) = 
1.89, and at 6 months ^^(3) = 2.92. 
These results were consistent with the split-plot analysis of 
variance conducted on the percentage reduction data. When the 
maintenance groups were combined, the RP groups at 6 months reported 
a higher abstinence rate than did the M groups (47.62% as opposed 
to 35.14%), although this difference was not significant. 
Nicotine content 
The third assessment of smoking behavior focused on the nicotine 
content of cigarettes consumbed by relapsers. Specifically, an 
analysis of variance indicated that the nicotine content of cigarettes 
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Table 4 
Percent of Subjects Abstinent by Group 
Group Week 1 Month 1 Month 3 Month 6 
NF-M 84 .21 73 .68 42 .11 26 .32 
AV-M 94 .44 72 .22 50 .00 44 .44 
NF-RP 83 .33 70 .83 62 .50 54 .17 
AV-RP 100. ,00 61, .11 55, .56 38 .88 
Combined M Groups 89. 19 72, .97 45, .95 35 .14 
Combined RP Groups 90. ,48 66. ,67 59. ,52 47, .62 
Combined AV Groups 97. 22 66. ,67 52. ,78 41. ,67 
Combined NF Groups 85. 72 72. ,09 53. ,49 41. ,86 
All Groups 89. 90 69. 60 53. 20 41. 80 
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relapsers smoked at follow-up varied significantly with the cessation 
treatment, F (1, 44) = 15,28, p<.001. Subjects in the AV treatments 
began the program with a mean nicotine level of .92, while subjects 
in the NF groups began the program with a mean nicotine level of 
.98. At the 6-month follow-up, relapsers from the AV groups 
were smoking cigarettes with a mean nicotine level of .87, as 
contrasted with the NF subjects who relapsed to significantly 
lower nicotine content cigarettes (mean level of .48 at 6-month 
follow-up). This result was consistent with the theoretical 
basis of the different cessation treatments as the NF subjects 
switched to lower nicotine content cigarettes during the program. 
Self-efficacy Analysis 
The confidence questionnaire (Condiotte & Lichtenstein, 1981; 
Appendix B) was administered three times during the program 
(pretreatment, quit date, and at the termination of treatment). A 
split-plot analysis of variance was performed to assess between-
group differences over time. No main effects for cessation, 
maintenance, or therapist were evident. However, several interactions 
attained significance. First, therapist by cessation by maintenance 
by time was significant, F (2, 116) = 4.27, p^.05. The two 
therapists had remarkably different impacts on the self-efficacy 
scores of the groups. Therapist one's groups reported increased 
self-efficacy scores throughout the treatment in three of the four 
groups. In contrast, therapist two's groups reported increases 
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in self-efficacy scores throughout the cessation portion of the 
program but not the maintenance phase in three of the four groups. 
Table 5 illustrates the mean group scores on the three administrati 
of the self-efficacy measure and the abstinence rates for each 
individual group. Interestingly enough, the two groups reporting 
the highest abstinence rate at 6 months were therapist one's 
NR-RP group and therapist two's AV-M group. The mean efficacy 
scores for both of these treatment groups increased throughout 
the course of treatment. However, it should be noted that 
self-efficacy is a process measure and that these differences 
were not reflected in the outcome data. 
Second, therapist by maintenance was significant, F (1, 58) = 
4.83, p<,05. Figure 3 illustrates the mean efficacy scores for 
each therapist by maintenance group. Again, the pattern described 
above was repeated. Therapist one's RP groups reported increases 
throughout the treatment program, while the M groups merely 
maintain their self-efficacy scores though the maintenance phase 
of treatment. In contrast, therapist two's groups reported 
increases in their self-efficacy scores to the quit date, followed 
by a decrease during the maintenance treatment. Theoretically, the 
RP treatment was designed to enhance the subjects' self-efficacy. 
This increase during maintenance occurred for therapist one, but 
not for therapist two. As will be discussed later, self-efficacy 
was the best predictor for treatment success. It was possible that 
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Table 5 
Self-efficacy and Abstinence by Groups 
Therapist 
& 
Groups Pre. 
Self-efficacy : 
Quit 
Scores® 
Term. 
Abstinence 
1 mo. 6 mo. 
Therapist 1: 
AV + M 40.74 70.58 62.52 75% 38% 
NF + M 38.67 72.17 77.57 78% 33% 
AV + RP 48.78 55.83 82.00 60% 40% 
NF + RP 49.29 77.25 93.16 83% 67% 
Therapist 2: 
AV + M 42.79 85.99 95.95 70% 50% 
NF + M 41.17 94.46 73.78 70% 20% 
AV + RP 46.81 83.60 68.29 63% 
CO C
O
 
NF + RP 39.22 75.84 72.28 58% 42% 
GThese are the mean scores for the individual groups. 
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1 
Termination Pre Quit 
Figure 3 
Comparison of Mean Efficacy Scores Across Treatment Times for 
Therapist and Maintenance Groups^ 
^Therapist 1 was delineated by a solid line, therapist 2 
by a broken line; RP groups delineated by o; M by •. 
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the differences between therapists in implementing the RP treatment 
may have obscured significant differences between the maintenance 
treatments. However, the self-efficacy termination scores for 
both therapists were so similar that they may have precluded 
the differences on the outcome measures of smoking rate. 
Third, therapist by time was highly significant, F (2, 116) = 
7.79, p <.001. Figure 4 demonstrates the mean efficacy scores for 
each therapist over treatment time. Again, the same pattern 
emerged, with therapist one's self-efficacy scores peaking at 
the quit date and then decreasing during the maintenance 
treatment. However, the overall self-efficacy scores at 
the termination of treatment for the two therapists were close 
(therapist one's = 78.81, and therapist two's = 77.57). 
Finally, a highly significant time effect emerged from 
the analysis, F (2, 116) = 103.75, p<.001. When the groups 
were collapsed across therapists, leaving the four basic 
treatment groups (NF-M, AV-M, NF-RP, and AV-RP), all of the 
group means of self-efficacy increased during the treatment 
program. Newman-Keuls comparisons were conducted to assess the 
nature of the differences in mean scores over time. These 
comparisons were chosen because the procedure was powerful and 
controlled for Type I error. Specifically, the comparisons 
indicate highly significant increases in the self-efficacy means 
both from the pretreatment assessment to the quit date, p-^.d. 
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W. 
Pre Quit Termination 
Figure 4 
Comparison of Mean Efficacy Scores for 
Therapists Across Time® 
^Therapist 1 was depicted by a solid line and therapist 2 by 
a broken line. 
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and from the pretreatment to the termination, p .01. 
Predictors of Treatment Success 
Correlational analysis 
An initial correlational analysis, computed to assess the 
degree of relationship between abstinence at 6 months and percentage 
reduction at 6 months, was highly significant (r = -.9586, p<.001). 
Therefore, percentage reduction at 6 months was utilized as the 
outcome measure in further analyses. Pearson product-moment 
correlations were performed to assess the degree and direction 
of relationships between outcome at 6 months and several 
variables believed to have an impact on outcome. The correlations 
are listed in Table 6. 
First, factors measuring group cohesion included the group 
cohesion questionnaire (Appendix V) and number of absences. 
Although the questionnaire did not correlate significantly with 
outcome at 6 months, number of absences was highly correlated 
with outcome (r = -.37, p<.001). In addition, number of 
absences could also be viewed as a measure of treatment adherence. 
Thus, the correlation of absences with outcome suggested that 
cohesion and adherence to treatment may have been related to 
outcome at 6 months. However, these conclusions are tenuous 
given that the cohesion questionnaire was not correlated with 
outcome at 6 months. 
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Table 6 
Correlation Matrix 
Self-efficacy 
Pre. Quit Term. 
Group 
Cohesion 
Absences 
Percentage 
Reduction 
at 6 mes. 1—*
 
ro
 
o
 
CO
 
.68** .17 1 CO
 
* Indicates p < .001 
** Indicates p<.0001 
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Second, the three administrations of the confidence 
questionnaire (Condiotte & Lichtenstein, 1981; Appendix B) were 
included in the correlational analysis. The adminstration of this 
questionnaire at the termination of treatment evidenced the strongest 
relationship to outcome at 6 months (r = .68, p^.OOl), suggesting 
that subjects' self-efficacy at the end of treatment was an 
important factor in long-term abstinence. 
A further correlational analysis was conducted to control 
for possible inflation in the original analysis due to the inclusion 
of subjects who had already relapsed before the termination of 
treatment. It was possible that subjects who had relapsed before 
the final self-efficacy measure would have scored much lower 
than nonsmokers on that measure and this would have resulted in 
a biased analysis. Therefore, this analysis excluded smokers 
who had relapsed during the maintenance treatment. The correlation 
of the termination self-efficacy scores for subjects not smoking 
during the maintenance phase of treatment with outcome at 6 months 
was also highly significant (r = .63, p^.OOl). This result 
strongly corroborated the prior analysis which suggested that 
the termination self-efficacy score was highly predictive of 
outcome at 6 months. 
Regression analysis 
A stepwise multiple regression was conducted to further assess 
the importance of a number of variables at predicting outcome at 
6 months. However, the regression analysis did not differ from 
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correlational analysis as the self-efficacy termination score 
remained the best predictor of percentage reduction at 6 months. 
However, the regression analysis did indicate that the termination 
efficacy score was highly correlated with the changes in self-
efficacy from pretreatment to termination (-.85) and with the 
changes in self-efficacy from quit date to termination (-.69), 
suggesting that these variables were excluded from the stepwise 
regression because they correlated so highly with the self-efficacy 
scores at termination. Thus, changes in self-efficacy over the 
time of treatment may also have been an important factor in 
treatment success. Finally, Figure 5 graphically illustrates 
the changes in mean self-efficacy scores for relapsers as opposed 
to nonsmokers at 6 months. Specifically, nonsmokers' self-efficacy 
scores increased throughout the treatment period, as contrasted 
with relapsers' scores which increased to the quit date and then 
decreased during the maintenance period. 
Relapse Interviews 
Of the 46 subjects who had relapsed by the 6 month follow-up, 
31 completed relapse interviews (67%). Only 45% of the relapsers 
in the M groups completed the interviews, as compared to an 85% 
completion rate in the RP groups. The author attempted to contact 
all of the relapsers by telephone. The difference in the response 
rate was a function of persons who could not be found and incomplete 
forms. When considering these results, it should be noted that the 
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1/ 
/El 
Pre Quit 
1 
Termination 
Figure 5 
Comparison of Mean Efficacy Scores across Treatment Times for 
Subjects Reporting Relapses or Abstinence at 6 Months® 
line. 
BRelapsers are represented by a broken line, nonsmokers by a solid 
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the sample size in the M groups may not be representative of that 
population. 
Several areas of interest emerged from the relapse interviews. 
First, 58% of the subjects reported relapsing in the evening, 
whereas only 13% relapsed in the morning, and 29% relapsed in the 
afternoon. Second, the home environment was the most likely 
setting for a relapse (58%), followed by work (23%), and 
restaurants and bars (19%). Third, in 61% of the relapses 
another smoker was present, as contrasted to 39% of the situations 
in which the subject was alone or with a nonsmoker. This last 
result was consistent with other literature suggesting that the 
presence of other smokers is strongly associated with relapses 
(Shiffman, 1982). 
Fourth, 84% of the subjects reported experiencing a 
negative affect state prior to relapse. Specifically, 12% of 
these subjects reported an angry interpersonal situation, 42% reported 
feeling anxious, and 46% reported they were depressed. Only 15% 
of the total relapse sample reported a positive mood state and 
all of these subjects were socializing and drinking alcohol. 
These results are also consistent with earlier reports in the 
literature concerning the strong relationship between smoking 
and negative affect states (Marlatt, 1980; Shiffman, 1982). 
Fifth, the relapse interview contained questions about 
attempts to cope with urges after smoking a cigarette. In the 
RP groups, 59% of the relapsers stated they continued to try 
86 
to cope with urges, while 41% of the RP subjects made no further 
coping attempts. In the M groups, only 33% tried to cope following 
a relapse and 67% made no effort to cope. Although these data must 
be interpreted with caution due to the small number of responses 
from the M groups, they do suggest that more people in the RP 
groups attempted to cope with urges following a lapse than did 
subjects in the M groups. 
Finally, the subjects who relapsed were asked to describe 
the effects of that first cigarette on diminishing their confidence 
levels. The data indicated that: 27% of the RP subjects and 
11% of the M subjects stated it had little or no effect, 50% of the 
RP subjects and 11% of the M subjects stated it had a moderate 
effect, 18% of the RP subjects and 56% of the M subjects stated 
it had a strong effect, and 5% of the RP subjects and 22% of the 
M subjects stated it completely demolished their confidence in 
their ability to abstain from further smoking. These data were 
also consistent with the philosophies of the two maintenance 
treatments. Subjects in the RP groups reported experiencing less 
of a decrease in their confidence levels than did subjects in the 
M groups. Subjects in the RP groups were exposed to information 
about the AVE, were told that a lapse did not mean they had failed, 
and exhibited fewer failure responses than did subjects in the M 
groups. 
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DISCUSSION 
Overview of the Hypotheses 
Comparison of maintenance treatments 
Although no significant differences emerged due to the 
maintenance treatments, the hypothesis that the RP program would 
be superior received partial support. When the maintenance 
groups were combined, the RP groups reported a higher abstinence 
rate than the M groups at 6 months, 47.62% as compared to 35.14%. 
Although these differences did not reach significance, they were 
in the predicted direction. Furthermore, the maintenance by time 
interaction in the split-plot analysis of variance indicated 
that the subjects in the RP groups relapsed at a slower rate 
than the subjects in the M groups. 
Finally, the relapse Interviews supported the effectiveness 
of the RP model. More subjects in the RP groups attempted to cope 
with urges to smoke than those subjects in the M groups. Also, 
RP subjects reported that the first cigarette had much less of 
a detrimental effect on their confidence levels than subjects 
in the M groups. Both of these findings supported the viability 
of the RP model. It would be interesting if future research 
focused more specifically on the actual smoking patterns of 
relapsers receiving different maintenance treatments to determine 
if the RP treatment had specific behavioral effects. 
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Thus, the outcome was in the expected direction but no significant 
treatment differences emerged. Several factors could have contributed 
to the lack of significant differences between the maintenance 
packages. First, the statistical power was severely limited by 
the number of subjects in the study (Cohen, 1977). Each of 
the four treatment conditions was represented by only two groups 
and total subject enrollment was only 79. Therefore, the 
results of the present study were not conclusive due to the 
limited statistical power. It is possible that replication 
of this study with a larger number of subjects might result 
in more conclusive findings. Replication is clearly indicated. 
Second, the use of the M treatment package provided a stringent 
baseline for comparison of the RP treatment. The M treatment 
has been proven clinically effective in previous experiments and 
has been one of the most effective smoking treatments to 
date (e.g., Lando, 1977; Lando & McCullough, 1978). In addition, 
it should be noted that the overall percentage reduction from 
baseline smoking rates at 6 months was 51.41%. This rate was 
relatively high and demonstrated the effectiveness of all of 
the treatment groups. As average outcomes for one year follow-
ups have usually been around 25% abstinence, the present study 
compares favorably to the established treatments (Lando, 1980). 
Third, although a trend emerged supporting the superiority 
of the RP model, the effects may have been somewhat weakened 
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by the complexity of the format. Researchers have suggested that 
increasing the number of interventions during treatment can 
actually result in decreased effectiveness of the treatment 
(Hall, 1980; Lando, 1980; Lichtenstein & Danaher, 1976). In 
the present study, an effort was made not to overload subjects 
in such a manner. For instance, subjects in the RP treatment 
groups were allowed time for free discussion and the 
introduction of techniques were spaced to give the subjects 
time to comprehend the topics. Thus, although the concern 
about the complexity of the treatment package was warranted, 
no evidence of overloading the subjects was apparent. 
Fourth, subjects exhibited mixed reactions to the presentation 
and discussion of the relapse fantasies and the AVE concept. 
Subjects who had relapsed prior to the discussion of the AVE found 
the experience appropriate and helpful. In contrast, subjects 
who had not smoked after the quit date were disconcerted when 
the therapists began talking about relapses and how to cope with 
them. Some subjects viewed this discussion as permission to smoke; 
some refused to participate; and some felt the therapists had 
lost confidence in them. 
In light of these subject responses, the AVE may have undermined 
the goals of the RP treatment. Similar concerns were expressed by 
Cooney et al. (Note 11). Future research should investigate the 
efficacy of the AVE discussion and especially the timing of the AVE. 
As it did appear helpful to subjects who had relapsed, it is possible 
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that waiting until a relapse occurs before discussing the AVE 
might be therapeutic. As this would be difficult to manage in 
an experimental study, an alternative would be to place more 
emphasis on the AVE discussion as being similar to a fire drill, 
i.e., it is useful to have the practice and knowledge but 
that does not mean that the fire (or relapse) will occur 
(Marlatt, 1980). 
Finally, the lack of significant differences between 
the treatments could have resulted from the different styles 
of the two therapists in implementing the maintenance treatments. 
Although no main effects emerged for therapists on the outcome measures 
or on the process variable of self-efficacy, numerous interactions 
involving the therapist factor attained significance. The two 
therapists had different impacts on the self-efficacy scores 
across treatment times, with therapist one's groups reporting 
continual increases in self-efficacy and therapist two's groups 
increasing dramatically to the quit date and then decreasing 
during the maintenance treatment. However, the termination scores 
for the different therapists were similar. Given the high correlation 
of the termination self-efficacy scores with outcome at 6 months 
and of the termination scores with changes throughout the treatment, 
the therapist differences evident in the interactions may have 
contributed to the lack of significant main effects. Future 
research should concentrate on the process of changing self-
efficacy reports of subjects to test the importance of this relationship. 
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Comparison of cessation treatments 
No predictions were made concerning the differential 
effectiveness of the AV and NF cessation treatments, although it 
was hoped that the structured RP package would enhance the 
outcome of the NF groups. In the present study, no significant 
differences emerged between the AV and NF treatments. Both 
cessation treatments were effective in reducing or eliminating 
smoking over the 6 month follow-up period, with an overall 
abstinence rate of 42% at 6 months. The significant time 
effect found in the split-plot analysis of variance indicated 
that all groups did significantly relapse over the 6-month 
follow-up period. 
The AV treatment has proven highly effective when part 
of a multicomponent treatment package (e.g., Lando, 1977, 1981). 
Although the initial study concerning the NF treatment reported 
a 40% abstinence rate at the 18-month follow-up, later 
investigators have not confirmed the efficacy of the treatment 
(e.g.. Beaver et al., 1981; Lando et al.. Note 5). At least 
one study (Etringer et al.. Note 7) has demonstrated that the 
NF procedure could be as effective as the AV when implemented in 
the context of a highly cohesive group. The results of the 
present study suggested that the NF treatment was as effective 
as the AV when combined with a structured maintenance package. 
Thus, the NF treatment format's efficacy has been demonstrated 
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when supplemented with other process variables (cohesion) or 
with structured coping skills training. 
A significant advantage to the NF treatment involves the 
decreased health risks during treatment which increases the 
applicability of the treatment to all smokers, regardless of 
health problems. Therefore, the increased effectiveness of the NF 
treatment when supplemented by a structured maintenance package 
has strong implications for further research and clinical practice. 
A further advantage to the NF treatment is that relapsers 
from this cessation treatment resumed smoking a lower tar and 
nicotine cigarette than their baseline brand (Beaver et al., 1981; 
Foxx et al., 1981). Although some investigators have reported 
an increase in smoking rate among those who switch to lower 
nicotine cigarettes (Goldfarb et al., 1976), others have found 
no compensatory increases in smoking rates (Beaver et al., 1981; 
Cherry & Forbes, 1972). In addition, laboratory tests have 
indicated that smoking lower tar and nicotine cigarettes resulted 
in concomitant decreases in the intake of poisonous gases (Prue 
et al., 1980). 
The present study found a highly significant cessation 
treatment effect on nicotine levels of cigarettes smoked by relapsers, 
with NF subjects returning to lower tar and nicotine cigarettes. 
Although the physiological effects of lower tar and nicotine 
cigarettes are still controversial, the present study was consistent 
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with the previous research findings that relapsers from NF 
cessation treatments smoke lower tar and nicotine cigarettes. 
Variables predicting success 
The best predictor of treatment success at 6 months was the 
last administration of the confidence questionnaire (Condiotte 
& Lichtenstein, 1981; Appendix B) which occurred at the termination 
of treatment. The additional correlational analysis which 
excluded subjects who relapsed prior to the termination of treatment 
reinforced the strength of the termination self-efficacy 
scores as predictors of successful outcome. The present 
study suggested that regular attendance might have increased 
self-efficacy ratings as the two factors were highly correlated. 
In addition, Figure 5 (p. 84) illustrated that continual 
increases in self-efficacy ratings throughout the entire 
treatment was associated with abstinence at the 6-month follow-up. 
The interaction effects on the self-efficacy split-plot 
analysis involving the therapist factor complicated the 
interpretation of the results. Differences between the therapists 
emerged only on a process variable. Investigation of therapist 
variables in relation to process and outcome measures are in 
beginning stages. Due to the difficulty in studying such factors, 
a recent review (Parloff, Waskow, & Wolfe, 1978) described the 
field as dealing with such simplistic, global concepts as to be 
suffering from "possibly terminal vagueness" (p. 273) and concluded 
94 
they were unable to discern the therapeutically relevant factors. 
However, some evidence exists favoring the importance of verbal 
and nonverbal stylistic variables among therapists (Parloff et al., 
1978). From the present study, the author is unable to reach 
conclusions about the causes or the effects of the differential 
impacts on self-efficacy ratings of the two therapists. Investigation 
of stylistic variables involved in these differences would have 
been worthwhile. For future research, investigating process 
variables might elucidate the reasons why many smoking 
studies do not result in differential effectiveness for the 
various treatments. 
A second factor with a strong relationship to successful 
outcome at 6 months was the number of absences. Attendance to 
groups could be viewed as a measure of treatment adherence 
and/or as a measure of group cohesion. The findings in the 
present study, that number of absences was highly correlated 
with percentage reduction at 6 months, supported the hypothesis 
that treatment adherence would be related to long-term success. 
Interestingly, the RP group members missed significantly fewer 
meetings than the M group members, suggesting greater attention 
and adherence in the structured groups. This could have been 
caused by the presentation of different exercises every week 
in the RP groups, as opposed to group discussion in the M groups. 
Further analyses indicated that RP members who had relapsed also 
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attended more maintenance sessions than M members who relapsed. 
Thus, relapsers in the RP groups evidently understood the 
rationale underlying the RP model, i.e., that a lapse should 
be viewed as a learning experience rather than a failure. 
The final variable included in these analyses was group 
cohesion. The cohesion questionnaire (Appendix V) and the 
number of absences were used in the correlational analysis 
to measure the cohesion of the groups. Both of these measures 
have been used in previous research to determine the degree 
of cohesion in smoking groups (Etringer et al., Note 7). 
That study found that highly cohesive groups were significantly 
more effective through 3 month follow-up than noncohesive 
groups (Etringer et al.. Note 7). Longer term follow-up 
interpretations concerning cohesion were made difficult by 
an inordinate amount of life changes producing extreme 
stress for subjects in the AV groups. Thus, comparisons 
between the groups must be interpreted with caution. 
The present study partially supported the relationship of 
group cohesion to treatment success. Specifically, number of 
absences was strongly related to outcome at 6 months. However, 
the cohesion questionnaire was not significantly related to 
long-term outcome. It was possible that the cohesion questionnaire 
was an inadequate measure of group cohesion in the present study. 
The scale consisted of only eight items and may not have been 
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sensitive enough to detect the cohesion processes, A scale 
with more items might provide a better index of cohesion. 
In the present study, the majority of the scores indicated 
that most of the subjects perceived their groups as cohesive. 
Future studies should continue to focus on cohesion 
and its relationship to outcome. Additional measures of 
cohesion could be used for more accurate assessment. For 
example, Etringer et al, (Note 7) found that the Hill 
Interaction Matrix (Hill, 1965) and the Comfortable Interpersonal 
Distance Scale (Duke & Nowicki, 1972) were appropriate measures 
for smoking studies. 
Implications for the RP Model 
Theoretical support 
Strong theoretical support for the RP model emerged from 
the relapse interviews. Situational variables surrounding the 
relapse process which were identified as important in previous 
literature were supported in the present investigation. For 
example, the setting of the relapse and the finding that more 
subjects relapsed while in the presence of another smoker than 
while alone or with a nonsmoker were replicated in the 
present study (Eisinger, 1971; Lichtenstein et al., Note 9; 
Shiffman, 1982). In addition, the association of negative 
affective states with relapses has been a central tenet in 
the development of the RP model (Marlatt, 1980; Marlatt & Gordon, 
1980). In the present study, 84% of the subjects who relapsed 
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reported a negative affect state prior to smoking. 
Findings also supported the rationale behind the RP model 
that a lapse should be viewed as a learning experience and not 
as a treatment failure. For instance, 59% of the RP relapsers 
attempted to cope after the initial lapse, as contrasted to only 
34% of the M relapsers. Further, RP relapsers missed fewer 
maintenance sessions than did M relapsers. 
Another significant finding was that 75% of the RP members 
stated that smoking that first cigarette had little to moderate 
effects in decreasing their self-confidence, as opposed to 78% of 
the M members who reported that the cigarette had a strong effect 
or completely demolished their self-confidence in their ability 
to abstain from smoking. The decrease in self-confidence due to 
a smoking experience was a result of the AVE according to the RP 
model. Thus, RP members coping and not describing themselves as 
failures with no self-confidence could have been due to the 
presentation of the AVE information and the basic treatment 
rationale of the RP model. Future relapse research should also 
focus on the behavioral effects of self-confidence and coping 
and how they relate to further smoking. 
In addition, the construct of self-efficacy operating as 
an underlying mechanism in behavior change also received support. 
Although the hypothesis that RP subjects would exhibit higher 
self-efficacy ratings due to the treatment was not supported, 
the hypothesis that relapsers would express lower self-efficacy 
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ratings was affirmed (Figure 5, p. 84). 
In recent years, self-efficacy has received increasing 
attention in the field of smoking research. Although one study 
(Cooney et al.. Note 11) reported that self-efficacy did not 
predict outcome, the majority of the literature has been positive. 
For example, DiClemente, (1981), comparing aversion therapy, 
behavioral management, and self-quitters, found that self-
efficacy ratings after 4 weeks of successful abstinence were 
significantly related to abstinence after 5 months. Finally, 
the most conclusive study to date (Condiotte & Lichtenstein, 
1981) demonstrated that termination self-efficacy scores 
predicted outcome at 3-month follow-up. The results of 
the present study indicated that termination self-efficacy 
scores predicted long-term success. The process variables 
influencing self-efficacy were probably important treatment 
ingredients. 
Empirical support 
The major finding that the RP treatment was not significantly 
more effective than the M treatment was consistent with previous 
research. First, Boelens (1980) found no significant differences 
at the 6-month follow-up period between an RP treatment and a 
multicomponent package. However, the results must be interpreted 
with caution due to serious methodological weaknesses in the study. 
Second, Brown and Lichtenstein (Note 10) conducted a clinical 
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evaluation of nicotine fading, self-management, and RP, and 
found a 46% abstinence rate at 6 months, but were unable to 
replicate this in a controlled study. In the latter, RP 
was not superior to a discussion control group (Brown & 
Lichtenstein, Note 10). 
Although the empirical literature has not demonstrated 
the superiority of the RP model, it has not been extensively 
tested. The present study has reported the most promising 
findings to date. At 6 months, the overall abstinence 
rate was 42%, comparing favorably with existing literature 
(Lando, 1980). Thus, both maintenance packages were effective. 
Concluding Remarks 
Clerarly, the author must recommend replication. The 
present study suffered from limited statistical power (Cohen, 
1977). Further, the interactions involving the therapist 
factor on the self-efficacy measure may have obscured treatment 
differences. Also, the complexity of the RP model may have 
been too demanding on the subjects. It would be useful to 
test the specific components of the RP model in different 
treatment packages to determine what interventions were the 
most effective. For example, the utility and timing of the 
AVE interventions should be tested. It could have been 
detrimental in the present study, considering the subjects' 
mixed reactions. 
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Finally, process variables have become increasingly important 
in psychological research. Smoking studies have just begun 
to focus on these variables. The present study indicated 
that self-efficacy was a powerful predictor of long-term 
outcome. Possible factors influencing self-efficacy could have 
been regular attendance, adherence, and therapist differences 
in implementing strategies and in their interpersonal styles. 
Future research should address the process variables operative 
within the cognitive-behavioral treatments to gain a better 
understanding of treatment with the goal of enhancing its 
effectiveness. 
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HORN WAINGROW SCALE 
Below is a list of 23 items regarding motives for smoking. Please 
rank how these items apply to your smoking habit using the following 
scale: 
1 = never 
2 = seldom 
3 = occasionally 
4 = frequently 
5 = always 
1. I smoke cigarettes to stimulate me, to perk myself up. 
2. I've found a cigarette in my mouth and didn't remember 
putting it there. 
3. When I am trying to solve a problem, I light up a cigarette. 
4. When I smoke a cigarette, part of the enjoyment is watching 
the smoke as I exhale it. 
5. I am very much aware of the fact when I am not smoking a 
cigarette. 
6. Part of the enjoyment of smoking a cigarette comes from the 
steps I take to light it. 
7. When I feel "blue" or want to take my mind off cares and 
worries, I smoke cigarettes. 
8. I smoke cigarettes automatically without even being aware of 
it. 
9. I smoke cigarettes in order to keep myself from slowing down. 
10. I get a real gnawing hunger for a cigarette when I haven't 
smoked for awhile. 
11. When I feel uncomfortable or upset about something, I light 
up a cigarette. 
12. Handling a cigarette is part of the enjoyment of smoking it. 
13. Between cigarettes, I get a craving that only a cigarette can 
satisfy. 
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14. I light up a cigarette when I feel angry about something, 
15. I light up a cigarette without realizing I still have one 
burning in the ashtray. 
16. I find cigarettes pleasurable. 
17. When I feel ashamed or embarrassed about something, I light 
up a cigarette. 
18. When I have run out of cigarettes I find it almost unbearable 
until I can get them. 
19. Few things help better than cigarettes when I'm feeling 
upset. 
20. I smoke cigarettes just from habit, without even really 
wanting the one I'm smoking. 
21. Smoking cigarettes is pleasant and relaxing. 
22. I do not feel contented for long unless I am smoking a 
cigarette. 
23. I smoke cigarettes to give me a "lift". 
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HORN WAINGROW SCORING SHEET 
1. Reduction of negative affect scale includes items: 
3. , 7. , 11. , 14. , 17. , 19. 
Total score = . A score of 21 or more is significant. 
2. Addictive scale includes items: 
5. , 10. , 13. , 18. , 22. 
Total score = . A score of 17.5 or more is significant. 
3. Habitual scale includes items: 
2. , 8. , 15. , 20. 
Total score = . A score of 14 or more is significant. 
4. Stimulation scale includes items: 
1. , 9. , 23. 
Total score = . A score of 10.5 or more is significant. 
5. Sensori-motor manipulation scale includes items: 
4. , 6. , 12. 
Total score = . A score of 10.5 or more is significant. 
6. Pleasurable relaxation scale includes items: 
16.  ,  21.  
Total score = . A score of 7 or more is significant. 
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CONFIDENCE QUESTIONNAIRE 
Below is a list of 49 different situations in which people smoke. 
Please designate the probability that you will be able to resist the 
urge to smoke in each situation. Use a IGO-point probability scale 
with 100 meaning that you are confident that you will be able to resist 
smoking and 0 meaning that you are sure you will not be able to resist 
smoking. Use only 10-interval numbers in your rating. Finally, rate 
the situations according to your feelings at this time. 
1. When you sit back and enjoy a cigarette 
2. When you feel anxious 
3. When you want something to do with your hands 
4. When you simply become aware of the fact that you are not 
smoking 
5. When you want to reward yourself for something you've done 
or tell yourself that you can have a cigarette if you 
complete some task 
6. When you find a cigarette in your mouth and don't remember 
having lit it 
7. When you are resting 
8. When you want to keep yourself busy 
9. When you feel depressed 
10. When you want to cheer up 
11. When you want to feel more mature and sophisticated 
12. When you light up a cigarette to go along with some activity 
you are doing {for example, while fixing a bicycle, writing 
a letter, doing housework) 
13. When you want to take a break from work or some other 
activity 
14. When you realize you are lighting a cigarette even though 
you just put one out 
15. When you feel tense 
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16. When you feel embarrassed 
17. When you realize you won't be able to smoke for awhile 
18. When you are worried 
19. When you are waiting for someone or something 
20. When you feel nervous 
21. When you are trying to pass time 
22. When you feel impatient 
23. When you feel bored 
24. When you are drinking coffee or tea 
25. When you realize you have run out of cigarettes 
26. When you want to have time to think in a conversation 
27. When you feel uncomfortable 
28. When you are angry with yourself 
29. When you feel you need more energy 
30. When you want to concentrate 
31. When you want something in your mouth 
32. When you want to fill a pause in a conversation 
33. When you want to relax 
34. When you want to keep slim 
35. When you feel angry 
36. When you feel annoyed 
37. When you want to feel more attractive 
38. When you feel tired 
39. When you are drinking an alcoholic beverage 
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40. When you feel frustrated 
41. When someone offers you a cigarette 
42. When you feel restless 
43. When you feel upset 
44. When you see others smoking 
45. When you are overly excited 
46. When you want to avoid eating sweets 
47. When you are in a situation in which you feel smoking is part 
of your self-image 
48. When you have finished a meal or snack 
49. When you feel oversensitive 
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CONFIDENCE QUESTIONNAIRE SCORING SHEET 
1. Restlessness scale includes items: 
1 . , 3. , 12. , 13. , 19. 
22. , 30. , 33. , 42. , 44. 
45. , 48. 
Total = , total divided by 12 = 
2. Negative interpersonal mood scale includes items: 
2. , 9. , 15. , 18. , 20. 
28. , 35. , 36. , 40. , 43. 
49. 
Total = , total divided by 11 = 
3. Crutch scale includes items: 
5. , 7. , 10. ,  26. ,.29. 
31. , 34. , 38. , 46. 
Total = , total divided by 9 = 
4. Time structuring scale includes items; 
4. , 8. , 21. , 23. 
Total = , total divided by 4 = 
5. Automatic scale includes items: 
6. , 14. , 17. , 25. 
Total = , total divided by 4 = __ 
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6. Negative interpersonal mood scale includes items: 
16. , 27. , 32. 
Total = , total divided by 3 = 
7. Social scale includes items: 
24. , 39. , 41. 
Total = , total divided by 3 = 
8. Self-image scale includes items: 
11. , 37. , 47. 
Total = , total divided by 3 = 
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UN^/ERSiTf' 
UNIVERSITY COUNSELING CENTE9 
OFUIAH 2120 ANNEX BulLDiNG SAl' LAKE Crv. UTAH 34112 801-531-6Ô26 
LETTER TO EMPLOYER 
Dear Employer: 
Would you please announce to your employees our Stop-Smoking 
Clinics which will begin (date) at the University of Utah Counseling 
Center. These clinics are supported by a federal grant and are 
offered as a public service to interested individuals. Costs to 
participants include a nominal $10 fee and a deposit of $10 which 
is refunded following the conclusion of the program. 
The clinics are based on over 10 years of clinical research 
and are among the most effective ever offered. It might be noted 
that our abstinence rates have been as high as 75% 5 months following 
the quit date. They in no sense represent a "magic cure", however. 
The programs are comprehensive and include everything that can 
be found in commerical programs costing several hundred dollars. 
They are federally supported and are intended primarily as a public 
service. 
Any of your employees who are interested should come to the 
orientation session (date). The session will be held in classroom 
2214 at the Counseling Center in the Annex Building, Wing B. The 
session will begin at (time) and last approximately 1 hour. The 
entire program itself will last about 9 weeks, including a maintenance 
program. Sessions will generally be held in the evenings and a choice 
of meeting times will be available. During the program all partici­
pants will undergo one week of intensive treatment during which they 
will be asked to attend sessions every weeknight. Most sessions will 
last approximately 1 hour. 
We would appreciate anything you can do to call the clinic to 
the attention of your employees. All cigarette smokers who would 
sincerely like to quit are invited to the orientation session. 
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An additional series of clinics will begin (date). If you 
have any questions or would like further information about the program, 
please call 581-6826. 
Sincerely, 
Vickie R. Gregory, M.S. 
For: Dr. Harry A. Lando 
Associate Professor of Psychology 
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INFORMED CONSENT FORM 
Please read the following material carefully. It contains a 
general description of the research project and procedures, as well 
as a description of any potential discomforts, risks, and benefits 
that may be involved. Please feel free to ask any questions about 
the material contained here. Your participation in this project 
is entirely voluntary and you may withdraw at any time without 
any penalty. 
The purpose of this project is twofold. The primary aim is to 
aid you in eliminating your smoking. To this end, you will be 
assigned to one of two treatment programs to be described below. 
These programs are among the most effective to be developed to 
date. Secondly, this is a research project aimed at developing 
the most effective smoking treatment possible. The reason for 
using two different treatments is to compare the relative effective­
ness of the two most successful programs. These treatments will now 
be briefly described. 
The first treatment is called intensive smoking and involves 
increasing your rate of smoking for a 1-week period. This procedure 
is aimed at helping you stop smoking by making the act of smoking 
and associated cues unpleasant. This procedure will involve some 
discomfort and possibly a degree of risk. 
Discomfort. The procedure may cause you some discomfort and 
this in fact can be very helpful in making the treatment work. 
Different people react in different ways. If you are asked to 
increase your number of cigarettes, you will be expected to try to 
double your normal smoking rate for a period of 1 week. You will 
follow this procedure during the laboratory sessions and on your own 
outside of the lab. Irritation of the throat, chest, tongue, and 
eyes may occur. However, you are to discontinue smoking immediately 
in the event that you find yourself becoming nauseous. 
Risk. Greatly increased smoking will greatly increase your 
intake of nicotine. The effect of this may be an increase in heart 
rate. This could conceivably be dangerous for persons with heart 
disease. This is why we asked you a number of questions about your 
medical condition, as well as asking all of you to obtain your 
physician's consent. If you do have known heart or vascular disease, 
then the intensive smoking procedures are not appropriate for you. 
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The second treatment is called nicotine fading, and involves 
gradually decreasing the nicotine content of the cigarettes you smoke. 
You will be asked to decrease the nicotine by successively switching 
to lower tar and nicotine cigarettes. In this fashion the nicotine 
in your system will be gradually reduced as will your physical 
dependence on it. The aim is to make total abstinence easier by 
reducing the degree of physical addiction. There may be some 
discomfort involved in switching brands. The reduced nicotine intake 
may result in some temporary physical changes (e.g., change in heart 
rate, lung capacity, gastro-intestinal discomfort). Some participants 
in past programs have also tended to increase the number of cigarettes 
smoked in order to compensate for the reduction in nicotine intake 
per cigarette. This may result in the same risk factors outlined 
for the intensive smoking procedure. For these reasons, we ask that 
participants in the treatment also have the physician's consent form 
signed. 
You will be assigned to the treatment conditions on a random basis, 
unless a particular procedure is ruled out by your physician. We 
believe, and research has documented, that the degree of discomfort 
or risk involved in either procedure is quite small and is far 
outweighed by the benefits of quitting. Far greater risk is involved 
in continuing to smoke than in participating in either procedure. 
Because of the research nature of this program, we will ask you 
to fill out forms asking for demographic information and to keep 
records of the number of cigarettes smoked. We will be asking for 
your names and addresses in order to organize the data collection and 
to facilitate mailing follow-up questionnaires. This information will 
be kept strictly confidential and only the group leaders will have 
access to it. This permission can be withdrawn at any time. Following 
collection and analysis of all data, the written records will be 
destroyed. 
INFORMED CONSENT AGREEMENT 
I have read the description of the smoking program and have had 
the opportunity to ask questions of the leaders. I have read the 
statements concerning the possible risks and discomfort involved. I 
hereby agree to participate and to cooperate in returning information 
on my smoking. 
Date Signature 
Witness 
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UNIVERSITY COUNSELING CENTER 
2120 ANNEX BUILDING 
SALT LAKE CITY, UTAH 64112 
801-581.6826 
MEDICAL CONSENT FORM 
Dear Doctor: 
has volunteered to participate in a 
research project aimed at comparing different methods of controlling 
the smoking habit. Based on our previous research, we think there is 
a very good chance that the project will help him/her to stop smoking. 
Some of the procedures to be used, however, may involve a degree of 
risk and it is in this regard that we have asked him/her to check 
with you and secure your approval. 
Some participants will be assigned to an aversive procedure we 
call "excessive" smoking. The smoker is asked to greatly increase 
his/her cigarette consumption. They will be expected to smoke at 
least twice their usual number of cigarettes for a period of 1 week. 
They will also smoke continuously for 25 minutes during each of 
six laboratory sessions. However, smokers will be cautioned that 
they should at no time smoke to the point of dizziness or nausea. 
In the event of such symptoms, they are instructed to immediately 
extinguish their cigarettes. 
We have found this procedure to be effective as part of a long-
term program which is also oriented toward the maintenance of non­
smoking. By itself it is not sufficient. The purpose of excessive 
smoking is to increase the unpleasantness of the act of smoking 
itself and to increase the smoker's determination to quit. By 
setting a specific target date for quitting at the end of the week 
of excessive smoking, and then by immediately introducing a 
comprehensive maintenance procedure, the long-term prospects for 
abstinence are significantly increased. 
Results of these methods have included abstinence rates as high 
as 76% at the 6-month follow-up. We and other researchers have 
used this procedure on many hundreas of persons without any known 
ill effects. However, the procedure does lead to considerable nicotine 
intake which will stress the cardiovascular system. Therefore, we 
wish to exclude anyone with a history of heart disease, vascular 
disease, or bronchitis. 
133 
About 90% of the nicotine in tobacco is absorbed into the body 
when smoking. There is an immediate rise in heartbeats per minute 
and arterial blood pressure. The production of epinephrine and 
norepinephrine is stimulated by nicotine as is the production of 
free fatty acids. These findings on human subjects are summarized 
in The Heart, by J. Willis Hurst, M.D., (Ed.), McGraw-Hill, 1974. 
In our own research we have found no more increase in heart rate with 
excessive smoking than with normal smoking. We did, however, find 
a significantly greater increment in carboxyhemoglobin levels. There 
are no reported episodes of excessive smoking producing acute cardiac 
or vascular symptoms in humans. 
The second treatment to which the client may be assigned is 
called nicotine fading, and involves gradually decreasing the nicotine 
content of the cigarettes smoked. Clients will be asked to decrease 
the nicotine by successively switching to lower tar and nicotine 
cigarettes. In this fashion the nicotine in his/her system will be 
gradually reduced as will physical dependence on it. The aim is to 
make total abstinence easier by reducing the degree of physical 
addiction. There may be some discomfort involved in switching 
brands. The reduced nicotine intake may result in some temporary 
physical changes (e.g., change in heart rate, lung capacity, and 
gastro-intestinal discomfort). Some participants in past programs 
have also tended to increase the number of cigarettes smoked in 
order to compensate for the reduction in nicotine intake per cigarette. 
This may result in the same risk factors outlined for the intensive 
smoking procedure. 
We ask that you review your information on your patient, conduct 
any further examinations you may think necessary, and then indicate 
whether you think this person has some condition that would contra-
indicate the use of excessive smoking. If there are medical grounds 
for this person not undergoing either procedure, please indicate this. 
Please feel free to contact our project if you have any questions. 
Thank you. 
Vickie R. Gregory, M.S., and Bruce D. Etringer, M.S. 
University Counseling Center 
University of Utah 
Salt Lake City, UT 84112 
581-6816 
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To my knowledge this patient has no medical contraindications 
to undergoing excessive smoking as described above. 
Date Signature , M.D. 
Comments 
Because of medical contraindications, I would recommend the 
patient be assigned to the nicotine fading procedure. 
Date Signature , M.D. 
Comments 
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SMOKING STUDY QUESTIONNAIRE 
Dr. Harry A. Lando 
Department of Psychology 
Iowa State University 
Ames, lA 50011 
Instructions: Please provide as accurately as you can all the infor­
mation requested below. Print clearly, please. 
1. a. Name 
b. Address ' Zip code 
c. Phone (home) (business) 
2. a. Age b. Weight c. Height 
3. Sex: M F 
4. a. Marital status: Single Married 
Divorced Widowed 
b. Number of children 
5. Average number of cigarettes smoked per day 
6. Kind of cigarettes usually smoked: 
a. Brand 
b. Filter Nonfilter 
c. Menthol Nonmenthol 
d. Hard pack Soft pack 
e. Length: Regular King 100 mm 
120 mm 
7. Do you sometimes smoke a pipe? Yes No 
If yes, how often? 
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Do you sometimes smoke cigars? Yes ' No 
How many years have you been smoking? 
a. How many times have you tried to stop smoking before? 
b. If you have tried before, what was the longest period of 
time that you were able to go without smoking? 
c. If you have tried before, why do you think you didn't succeed? 
Why do you wish to give up smoking? 
Has your family physician or any other doctor ever advised you 
to quit smoking? If so, please describe that person's advice. 
Please describe any pressure or requests that you have had from 
family, friends, or co-workers to reduce your smoking or quit 
altogether. 
Do you have a current health problem that makes it especially 
important that you give up cigarettes? If so, what is it? 
Please identify other individuals in your family who currently 
smoke. 
If other people in your family do smoke, are they interested in 
quitting? 
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Among your friends would you say that: almost all of them 
smoke the majority of them smoke about half of 
them smoke some smoke, but not very many almost 
none of them smoke 
Among your co-workers would you say that: almost all of them 
smoke the majority of them smoke about half of 
them smoke some smoke, but not very many 
almost none of them smoke not applicable 
Do you drink coffee, tea, or cola? If so, approximately how 
many cups or glasses of each are you likely to average per day? 
Do you drink alcoholic beverages? If so, in a typical week how 
much are you likely to drink? 
Beer 
Wine 
Hard liquor 
Do you exercise on a regular basis? If so, please describe the 
activity and how often you are likely to engage in that activity 
in a typical week. 
Approximately how many pounds over (or under) your ideal weight 
are you in your opinion? 
How much of a problem do you think weight gain is likely to be 
for you once you quit? 
a. a very serious problem 
b. a problem, but not too serious 
c. only a small problem 
d. no problem at all 
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Have you ever participated before in a special project or formal 
treatment designed to help you stop smoking? Please explain. 
Describe any withdrawal symptoms that you experienced in previous 
attempts to quit and indicate how long these symptoms lasted. 
How did you learn of this stop smoking clinic? 
a. Friend or family member b. At work 
c. Radio ' d. Poster e. Newspaper 
f. Television g. Doctor h. Other 
We plan to conduct long-term follow-ups on everyone who completes 
our program. Please list the names and telephone numbers of 3 
people who know you very well. We would like to be able to 
contact these people to check on your smoking, especially if 
you should leave the area, 
1.  
2 .  
3. 
Have you suffered from any lung disorder, heart disorder, or any 
other chronic illness? If yes, please give details. 
Are you currently taking medications (pills, injections, etc.)? 
If yes, give details. 
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28. Have you had a recent physical examination and/or chest X-ray? 
If yes, by whom and for what reasons? 
29. Have you been hospitalized in the past 5 years. If yes, where 
and why? 
30. Do you know of any other information that we should consider 
in assigning you to a particular stop smoking treatment? 
Date 
Signature 
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FEDERAL TRADE COMMISSION NICOTINE CONTENT REPORT 
BRAND TYPE® NICOTINE^ 
Carl ton king size, hardpack 0.05 
Benson & Hedges reg. size, hardpack 0.1 
Carl ton king size, menthol 0.1 
Carl ton king size 0.1 
Tareyton Ultra Low-Tar king size, menthol 0.2 
Now king size, menthol, 
hardpack 0.2 
Now king size 0.2 
Now king size, menthol 0.2 
Now king size, hardpack 0.2 
Triumph king size, menthol 0.3 
Iceberg lOO's 100 mm., menthol 0.3 
Lucky 100's 100 nm., 0.3 
Kent III king size 0.3 
Decade king size, menthol 0.4 
Decade king size 0.4 
True king size, menthol 0.4 
True king size 0.4 
Triumph king size 0.4 
Carlton 100's 100 mm., menthol 0.4 
Dorai II king size, menthol 0.4 
Carlton lOO's 100 mm. 0.4 
Doral II king size 0.5 
Pall Mall Extra Light king size 0.5 
Lark Lights king size 0.5 
Meri t king size 0.5 
Lark Lights 100 mm. 0.5 
Tempo king size 0.5 
Meri t king size, menthol 0.5 
L & M Lights king size 0.5 
Tareyton Lights king size 0.5 
L & M Lights 100 mm. 0.5 
American Lights 120 mm. 0.5 
Lucky Ten king size 0.7 
Bel air 100 mm., menthol 0.7 
Parliament Lights king size 0.7 
Kool Super Lights 100 mm., menthol 0.7 
Parliament Lights king size, hardpack 0.7 
Tareyton Long Lights 100 mm., filter 0.7 
3A11 cigarettes are filter unless otherwise specified. 
^Nicotine is measured by milligrams per cigarette. 
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BRAND 
Arctic Lights 
Kent Golden Lights 
Kool Super Lights 
Real 
Merit 100's 
Kent Golden Lights 
Viceroy Rich Lights 
Benson & Hedges Lights 
Kultifilter 
Silva Thins 
Merit 100's 
Benson & Hedges Lights 
Marlboro Lights 
Raleigh Lights 
Old Gold Lights 
Raleigh Lights 
American Lights 
Multifilter 
Newport Lights 
Vantage 
Viceroy Rich Lights 
Kent Golden Lights 
Vantage 
Bel air 
Arctic Lights 
Marlboro Lights 
True 100's 
Kent Golden Lights 
Salem Lights 
True 100's 
Parliament Light 100's 
Kool Mi Ids 
Real 
Marlboro 
Kent 
Viceroy 
Salem Long Lights 
Camel Lights 
L & M 
Alpine 
Tareyton 
Vantage 
TYPE NICOTINE 
king size, menthol 0.7 
king size, menthol 0.7 
king size, menthol 0.7 
king size, menthol 0.7 
100 mm. 0.7 
king size 0.7 
king size 0.7 
100 mm., menthol 0.7 
king size 0.8 
100 im., menthol 0.8 
100 mm., menthol 0.8 
100 mm. 0.8 
king size 0.8 
100 mm 0.8 
king size 0.8 
king size 0.8 
120 mm., menthol 0.8 
king size, menthol 0.8 
king size, menthol 0.8 
king size, menthol 0.8 
100 mm. 0.8 
100 mm. 0.8 
king size 0.8 
king size, menthol 0.8 
100 mm., menthol 0.8 
100 mm. 0.8 
100 mm. 0.8 
100 mm., menthol 0.8 
king size, menthol 0.8 
100 mm., menthol 0.8 
100 mm. 0.8 
king size, menthol 0.8 
king size 0.9 
king size, menthol 
hardpack 0.9 
king size 0.9 
king size 0.9 
100 mm., menthol 0.9 
king size 0.9 
king size, hardpack 0.9 
king size, menthol 0.9 
king size 0.9 
100 m. 0.9 
1^4 
BRAND TYPE NICOTINE 
Pall Mall Lights 100 m. 0.9 
Marlboro king size, menthol 0.9 
Doral king size, menthol 0.9 
Virginia Slims 100 mm., menthol 0.9 
Chesterfield king size 0 .9  
Kent king size, hardpack 1.0 
Tareyton 100 mm. 1.0 
Eve 120 mm., hardpack 1.0 
L & M king size 1.0 
Oasis king size, menthol 1.0 
Raliegh king size 1.0 
Virginia Slims 100 mm. 1.0 
Doral king size 1.0 
Eve 120 nrn., menthol, 
hardpack 1.0 
DuMaurier king size, hardpack 1.0 
Saratoga 120 mm., menthol, 
hardpack 1.0 
Silva Thins 100 rnn. 1.0 
Winston Lights 100's 100 mm. 1.0 
L & M 100 mm. 1.0 
L & M 100 mm., menthol 1.0 
Kent 100 mm. 1.0 
Eve 100 mm., menthol 1.1 
Galaxy king size 1.1 
Eve 100 mm. 1.1 
Philip Morris International 100 mm., menthol, 
hardpack 1.1 
Benson & Hedges 100 mm., menthol 
hardpack 1.1 
Winston Lights king size 1.1 
St. Moritz 100 mm., menthol 1.1 
Marlboro 100 Iran. 1.1 
Camel Lights 100 mm. 1.1 
Marlboro 100 mm., filter, 
hardpack 1.1 
Spring 100's 100 mm., menthol 1.1 
Viceroy 100 mm. 1.1 
Chesterfield 100 mm. 1.1 
Benson & Hedges 100 mm., hardpack 1.1 
Raleigh 100 Iran. 1.1 
St. Moritz 100 mm., hardpack 1.1 
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BRAND TYPE NICOTINE 
Philip Morris International 100 mm., hardpack 1.1 
Marlboro king size» hardpack 1.1 
Salem king size, menthol 1.1 
Marlboro king size 1.1 
Saratoga 120 mm., hardpack 1.1 
Kool reg. size, nonfilter, 
menthol 1.1 
Benson & Hedges 100 mm., menthol 1.1 
Benson & Hedges 100 mm. 1.1 
Lark king size 1.2 
Salem king size, menthol, 
hardpack 1.2 
Kent 100 mm., menthol 1.2 
Kool 100 mm., menthol 1.2 
Newport king size, menthol. 
hardpack 1.2 
Pall Mall 100 mm., menthol 1.2 
Montclair king size, menthol 1.2 
Pall Mall king size 1.2 
Old Gold Filters king size 1.2 
Newport king size, menthol 1.2 
Lark 100 mm. 1.3 
Kool king size, menthol 1.3 
Winston lOO's 100 mm. 1.3 
Kool king size, menthol. 
hardpack 1.3 
Twi St  100 rran., lemon/ 
menthol 1.3 
Pall Mail 100 mm. 1.3 
Piedmont reg. size, nonfilter 1.3 
Long Johns 120 mm. 1.3 
Tall 120 mm., menthol 1.3 
Raleigh king size, nonfilter 1.3 
Philip Morris reg. size, nonfilter 1.3 
Benson & Hedges king size, hardpack 1.4 
Long Johns 120 mm., menthol 1.4 
Winston king size, hardpack 1.4 
Max 120 nm., menthol 1.4 
Chesterfield reg. size, nonfilter 1.4 
Camel king size 1.4 
Max 120 mm. 1.4 
Old Gold 100's 100 mm. 1.4 
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BRAND TYPE NICOTINE 
Winston 100 mm., menthol 1.4 
Lucky Strike reg. size, nonfilter 1.4 
Picayune reg. size, nonfilter 1.4 
Winston king size 1.4 
Pall Man king size, nonfilter 1.4 
Tall 120 m. 1.5 
Home Run 120 mm.J nonfilter 1.5 
Newport 100 mm., menthol 1.5 
Salem 100 mm., menthol 1.5 
Old Gold Straights king size, nonfilter 1.5 
Fatima king size, nonfilter 1.6 
Chesterfield king size, nonfilter 1.7 
Philip Morris Commander king size, nonfilter 1.7 
Herbert Tareyton king size, nonfilter 1.7 
English Ovals reg. size, nonfilter;, 
hardpack 1.8 
More 120 mm. 1.8 
Camel reg. size, nonfilter 1.8 
Half & Half king size 1.8 
More 120 nmi., menthol 1.8 
Players reg. size, nonfilter, 
hardpack 1.9 
Bull Durham king size 1.9 
English Ovals king size, nonfilter, 
hardpack 2.4 
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PHYSIOLOGICAL INFORMATION 
Statistics 
This information is not intended as a scare tactic. All of you 
realize that smoking is harmful to your health. What I want to do 
now is to give you some more information. Cigarette smoking is 
the leading preventable cause of death. Recent epidemiological and 
biomedical research has indisputably demonstrated that smoking is 
a significant causal factor in numerous serious diseases, including 
lung cancer, coronary heart disease, emphysema, chronic bronchitis, 
ulcers, and various other cancers. Investigators estimate that 
more than 37 million Americans will die prematurely as a result of 
smoking. The annual mortality rates directly attributable to smoking 
are staggering with: 80,000 deaths resulting from lung cancer, 
22,000 deaths from other cancers, 19,000 deaths from chronic pulmonary 
disease, and perhaps 225,000 deaths from cardiovascular disease. 
Cigarette smoking by pregnant women, when compared to pregnant 
nonsmokers, has been found to result in a higher rate of stillbirths, 
babies with lower birth weights, and infants with higher late fetal 
and neonatal death rates. 
Physiological effects 
Nicotine is a naturally occurring substance found in tobacco. 
Within 7 seconds after inhaling nicotine, it affects the brain. At 
the neural level, it has a biphasic effect. Specifically, it initially 
stimulates neural transmission and then has a depressant effect as 
it builds up and blocks neural transmission. Although some experimen­
tation has been done testing the usefulness of applying nicotine 
externally to bruises, it's therapeutic usefulIness has not been 
established. In fact, it is used in insecticides. 
The average cigarette contains about 1% nicotine. Cigars have 
10 times this amount. In addition to nicotine, experimenters have 
isolated more than 500 compounds from cigarette smoke. Thus, the 
effects of cigarettes on different individuals is unpredictable. 
In addition, tolerance develops to the effects of nicotine the longer 
one smokes. 
When you smoke, 10% of the nicotine from the cigarette is 
inhaled. Of this, 90% is absorbed into the blood stream. The 
carcinogenic effects of smoking are probably not due to nicotine, but 
to the other compounds in the cigarette. When you smoke: your heart 
rate increases, vaso-constriction of the blood vessels occurs (e.g. 
that is why people experience cold hands and possible numbness in 
their extremities), blood pressure increases, cardiac output increases, 
skin temperature decreases, and skeletal muscle tone decreases (e.g. 
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people who smoke wrinkle earlier and faster), alpha waves decrease, 
stomach contractions are inhibited, digestive processes slow down, 
the sensitivity of taste buds are decreased, and there is an increase 
in saliva. 
The tars and carbon monoxide from cigarettes contribute to health 
problems. Shortness of breath is due to the inhalation of carbon 
monoxide while smoking. The carbon monoxide combines with the 
hemoglobin in the red blood cells to form carboxyhemoglobin. Basically, 
this decreases the ability of the blood to carry oxygen. All tobacco 
smoke contains carbon monoxide. 
When a person quits smoking: the metabolic rate decreases, 
the heart rate decreases by about 3 beats per minute, there is a 10% 
reduction in oxygen consumption, blood pressure drops, and REM 
sleep increases. Possible withdrawal symptoms include: craving, 
irritability, restlessness, feelings of dullness, sleep disturbances 
ranging from drowsiness to insomnia, gastro-intestinal distrubances, 
anxiety, headaches, and impairment of concentration, judgment, and 
psycho-motor performance. Not all people experience withdrawal 
symptoms but it is important to know what they are. They can start 
from a few hours to a few days after quitting smoking and can last 
for a few days to a month. Few people that I have seen in these 
clinics experience these for a month. 
The important thing to remember about stopping smoking is that 
your health begins to improve immediately. Unless you have damaged 
your lungs to the point of developing emphysema, they will begin to 
return to their healthy state. When you smoke, the cilia in the 
lungs are paralyzed. The function of the cilia is to cleanse the 
lungs through a sweeping action. So when you stop smoking, you may 
begin to cough up the tenacious sputa which has accumulated in your 
lungs. This is a sign that the cilia are working again and your 
lungs are cleansing themselves. People who stop smoking notice 
such things such as, food tasting, ability to walk faster, etc. 
At this point, further questions are addressed. 
150 
APPENDIX I 
IMPORTANT SUGGESTIONS 
151 
IMPORTANT SUGGESTIONS 
1. Throw away all of your cigarettes. Do not leave them around to 
tempt you. 
2. Use gum or lifesavers (or anything else you can think of) as 
substitutes. For calorie watchers, munch on celery or some 
other low calorie food. Drink liquids. Keep your mouth 
occupied without resorting to cigarettes. 
3. Engage in moderate exercise. Fight the urge to smoke by taking 
a walk (leaving cigarettes behind). Do some gardening, play 
golf, swim, etc. If you resist that urge, it will pass. In 
situations where it is impractical for you to go outside and 
exercise (such as at work), immerse yourself in what you are 
doing. This will help you to keep your mind off cigarettes. 
4. Take a few deep breaths. It is amazing how refreshing this can 
be in the absence of cigarette smoke. You can heighten the 
sensation of freshness by brushing your teeth, gargling with 
mouthwash, or consuming a mint. 
5. Remember the positive aspects of nonsmoking. Notice how much 
more energy you seem to have, how much better your food tastes, 
and how much better and more healthy you feel. 
6. Think back to the week of treatment and remind yourself of the 
distinct lack of pleasure that you derived from smoking. People 
often find that this suggestion is particularly helpful. 
7. Remember your reasons for participating in treatment, as well as 
all of the effort you have made to break your smoking habit. Ask 
yourself if any cigarette can really be worth the risk of 
jeopardizing your goals. 
8. Be good to yourself. Think about the satisfaction that comes 
from mastering the urge to smoke. Put aside the money that you 
would have spent on cigarettes. Do this each day. You will be 
surprised at how quickly it will add up! Use this money to buy 
yourself something that you really want (preferably something 
that you would not otherwise get). 
9. Enlist the encouragement of your family and friends. 
10. Avoid situations where possible in which you would be particularly 
tempted to smoke, at least for the first two weeks after quitting. 
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For some people this means temporarily giving up coffee or 
drinking. For situations which you cannot avoid, you might 
take one of the smoking substitutes suggested above. 
11. Use these suggestions as you see fit. People usually find some 
suggestions to be more helpful than others. Apply these 
suggestions that best fit your situation. You might, for example, 
prefer to master situations in which you are tempted to smoke 
right from the outset. You should be the judge in each case. 
12. Try to come up with additional ideas of your own to help you 
refrain from smoking. Thinking of such ideas can be a useful 
exercise in itself. Carry this page with you and as ideas 
occur to you, note them on the back. 
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CONTINGENCY CONTRACT 
Agreement 
I will refrain from smoking for the following period: 
Consequences 
If contract is kept: 
If contract is broken: 
Today's date 
Review date 
Signed 
Witness 
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SELF-MANAGEMENT CONTRACT 
I promise that for each cigarette I smoke between 
and ' I will forfeit the sum of $ to be collected 
by ' within 48 hours of the time that I 
smoke. I promise to honestly and accurately report all smoking. 
Name ^ Date ' 
Witness 
157 
APPENDIX L 
SELF-MONITORING REASONS FOR SMOKING 
158 
SELF-MONITORING REASONS FOR SMOKING 
The reasons for smoking that you are to use for the self-
monitoring exercise are defined as follows. 
1. Stimulation = S. Stimulation smoking occurs when smoking gives 
you a sense of stimulation, helps you wake up, keeps you going, 
or assists you in organizing your energy. 
2. Manipulation = M. Manipulation is the act of handling the 
cigarette or the steps involved in the process of lighting 
a cigarette, watching the smoke curl upward, or exhaling the 
smoke. If these things give you satisfaction and/or are 
gratifying, this should be listed as a reason. 
3. Negative affect reduction = N. This is when smoking serves to 
reduce feelings of anger, distress, or pressure; smoking is 
specific to situations in which negative feelings are aroused; 
or smoking during moments of distress gives you a feeling of 
tranquility or helps you in handling a problem or crisis. 
4. Addiction = A. This occurs when you experience a strong 
craving for a cigarette, feel that you must have one or the 
craving will be unbearable, or when you have felt you needed a 
cigarette simply because it's been awhile since the last one. 
5. Pleasurable relaxation = P. This occurs when you smoke under 
pleasant circumstances, e.g. when relaxing at the end of a meal, 
during social conversations. List this if smoking increases 
your pleasure. 
6. Habit = H. Habit should be recorded when smoking involves 
minimal awareness, it is not rewarding or satisfying, or you 
light up automatically. 
Note. This list was adapted from the material in Joffe et al., 
1981. 
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RATIONALIZATIONS 
The following statements are rationalizations that people 
frequently use in returning to smoking. The purpose of this exercise 
is for you to become familiar with these thoughts and to use them 
as cues to implement coping strategies to avoid a lapse. In 
addition, it is important for you to add any of your own thoughts or 
statements that will facilitate returning to smoking. 
1. I could think more clearly if I had a cigarette, 
2. A cigarette sure would taste good. 
3. I've been smoking for years, another day won't matter. 
4. I'll just have one. 
5. No one will know. 
6. If I don't have a cigarette, I'll go crazy. 
7. A cigarette would help me to relax and calm down. 
8. With all these hassles, I really deserve a cigarette. 
9. I can't stand the thought of never smoking again. 
10. Maybe I'll just take one puff. 
11. I wonder what a cigarette would taste like. 
12. Smoking really wasn't so bad. 
13. How come they can smoke and I can't? 
14. I could get through this mess if I could only smoke. 
15. I'm beginning to gain weight and I could lose it if I started 
smoking again. 
16. I really enjoyed smoking. I liked the taste. 
17. I can't stop smoking because I don't have any willpower. 
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18. I get so nervous when I don't smoke. 
19. My friends say I am so irritable since I quit smoking. 
20. I think I'll reward myself for a month of not smoking by having 
just one cigarette. 
What are your rationalizations? 
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PHASES AND EXAMPLES OF COPING 
Stage of preparing for a stressor or craving 
What is it I have to do? 
I can develop a plan to deal with it. 
Just think about what I can do about it. That's better than getting 
anxious. 
No negative self-statements, just think rationally. 
Don't worry. Worry won't help anything. 
Stage of confronting and handling the stress or craving 
Just "psych" myself up. I can meet this challenge. 
One step at a time: I can handle the situation. 
Don't think about the craving, just what I have to do. Stay 
relevant. 
This craving is what they said I would feel. It's a reminder to 
use my coping exercises. 
This craving can be an ally, a cue to cope. 
Relax. I'm in control. Take a deep breath. 
Stage of coping with the feeling of being overwhelmed 
When the craving comes, just pause. 
Keep a focus on the present. What is it I have to do? 
I'll label my craving from 1 to 10 and watch it decrease. 
Don't try to eliminate the craving entirely, just keep it 
manageable. 
I can convince myself to do it. I can rationally reason the 
craving away. 
It will be over shortly. 
It's not the worst thing that can happen. 
Just think about something else. 
Do something that will prevent me from thinking about the craving. 
Stage of reinforcing self-statements 
It worked! I was able to do it! 
Wait until the group hears about this. 
It wasn't as bad as I expected. 
I made more out of this than it was worth. 
My ideas, that's the problem. When I control them, I can control 
the craving. 
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It's getting better each time I use the procedure. 
I'm really pleased with the progress that I'm making. 
Purposes of the self-statements 
These self statements are designed to be models to aid you to: 
a. assess the reality of the situation, 
b. control negative, self-defeating ideas, 
c. acknowledge, use, and possibly relabel the craving you are 
experiencing, 
d. "psych" yourself up to perform the necessary tasks, 
e. cope with the cravings you may experience, and 
f. reinforce yourself for having coped. 
Note. This format was adapted from Meichenbaum (1977), 
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PROBLEM-SOLVING APPROACH 
1. Recognize and label the problem situation. 
What is the situation? 
What is the usual response? 
What are you thinking/telling yourself? 
What do you feel like? 
Assess reality. 
2. Identify alternate responses to the situation. 
3. Evaluate the alternative responses. 
4. Choose and implement an alternative. 
5. Evaluate the alternative. Either continue to use it or 
choose an alternative. 
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CONTRACT TO LIMIT USE 
I, , realize that stopping 
smoking is difficult. Further, I am aware that many people smoke 
after they have quit. I want to quit smoking and am making a commit­
ment to do so. However, realizing the difficulty involved, I am 
willing to agree to the following terms in order to facilitate not 
smoking. 
1. I will delay smoking a cigarette for at least 20 minutes 
after the initial temptation or urge to smoke. 
2. Any lapse will involve only 1 cigarette. 
3. If I have 1 cigarette, I will delay any further smoking for 
at least 1 hour. During this time, I will engage in coping 
strategies designed to avoid smoking. I will also mentally 
review my reasons for not smoking and consider the long-
term consequences of smoking. 
I also realize that these terms are not meant to give me per­
mission to resume smoking. This contract is in effect until 
Signed 
Date 
Witnessed by 
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COPING WITH URGES 
Definition 
Urges consist of emotions, sensations, and cognitions which 
occur when a person experiences a strong impulse or need to smoke. 
Prior to cessation, an urge was the same thing as a cue to smoke. 
Now that you have quit smoking, you will experience an urge 
differently. It will become a cue to cope, rather than to smoke. 
Smoking can be conceptualized as a chain of events. Initially, 
a cue to smoke is present. This leads to an urge, and then to 
smoking or coping. The model is diagrammed below. 
CUE URGE SMOKE 
COPE 
Smoking cues 
A cue for smoking can be anything that elicits a desire to 
smoke. To facilitate your recognition of urges, they will be 
divided into specific categories. First, internal cues include 
depression, irrational beliefs, anxiety, etc. Second, external 
cues come from the environment and may include presence of other 
smokers, "smoke talk", advertisements, life stressors, etc. Third, 
conditioning process cues are strong associations you have with 
cigarettes, e.g. smoking while drinking alcoholic beverages, 
after meals, etc. Finally, experiencing urges is a natural part of 
breaking the smoking habit. 
Form A will be utilized to detail your own smoking cues. 
The urge 
Returning to the model described above, it is important to 
classify your urges. Again, urges consist of cognitive, affective, 
and physiological components. 
Cognitive aspects of the urge include all the thoughts, beliefs, 
and mental imagery which relate to and encourage smoking. For example, 
the following statements are cognitive aspects of an urge: "I really 
need a cigarette", "if I can have just one cigarette, I will be 
able to cope with this situation", and "one cigarette won't matter". 
It is important to delineate your cognitions in your urge situations. 
Affective aspects of an urge include the emotions one experiences 
during the urge. Examples involving the affective part of an urge 
include anxiety, fear, excitement, and guilt. 
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Finally, the physiological component of an urge consists of 
physical sensations during an urge. Examples include withdrawal 
symptoms, aching in the chest, and coughing. 
Use Form B to describe these components in terms of your 
own urges. 
Fluctuation of urges 
Urges tend to vary among individuals. Some individuals have 
urges for cigarettes for a longer time period than others. Anniver­
saries of not smoking may be accompanied by urges. Many times ex-
smokers attempt to reward themselves for a month of abstinence by 
having a cigarette. 
It is important to remember that; urges will become less 
frequent as time passes, they are not fatal, the actual urge 
will pass, and you can cope. 
Smoking pay-offs vs. long-term consequences 
It is important to understand your pay-off for smoking. People 
have reasons for returning to smoking. What are your short-term 
pay-offs for smoking? In order to cope with these, it is important 
to realize the long-term consequences of smoking. In the midst 
of an urge, the long-term consequences become unclear. Recalling 
these is an effective coping mechanism to assist you in not smoking. 
Use Form C to delineate these for yourself. 
What to do when you have an urge 
1. Recognize the urge--don't try to ignore it. 
2. Relax. Tell yourself you can handle the situation. 
3. Stop and anlyze the situation as in the self-instructional 
approach. What is the situation? What is the usual 
response? What are you thinking and telling yourself? 
How do you feel? Why do you want to smoke? 
4. Think of the consequences (immediate vs. long-term). 
5. Remember your alternatives. 
6. Make your decision. 
7. Reward yourself for not smoking. 
8. Share the situation with someone who understands how difficult 
it is to stop smoking. 
9. Consider the question, did you plan it unknowingly? 
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FORM A 
Identifiable signs that indicate you are experiencing an urge to smoke. 
Internal 
External 
Conditioning 
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FORM B 
Detail the various aspects of your own urges. 
Cognitive 
Affective 
Physical 
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FORM C 
Detail the short-term pay-offs vs. the long-term consequences. 
Short-term pay-offs Long-term consequences 
Note. This form was adapted from Salt Lake Veteran's Administration 
Hospital manual (Note ) and Taylor and Lantinga (Note ). 
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GAME PLAN WORKSHEET 
1. Describe the urge situation (when, where, who is with you) 
2. How did you feel? 
3. What did you think/tell yourself? 
4. What did you do to avoid smoking? 
5. What are some other alternatives you could use for similar 
situations in the future? 
Plan A: 
Plan B: 
Plan C: 
Note. This material was adapted from the Salt Lake Veteran's 
Administration Hospital manual (Note 13). 
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ABSTINENCE VIOLATION EFFECT WORKSHEET 
The abstinence violation effect (AVE) is the feeling that once 
you have smoked a cigarette, you have blown it. You feel guilty, 
like a failure, ashamed, and a variety of other negative emotions. 
It leads to a decrease in self-efficacy and to continued smoking. 
Components of the AVE 
1. You smoke. You are in a high-risk situation (e.g. anxious, 
around other smokers, drinking alcohol, or experiencing 
negative emotions), you smoke and feel as though you have 
failed. You didn't deal directly with the problem. 
Instead, you had a cigarette. 
2. You feel conflict. Your commitment to yourself, the group, 
and your contract said one thing and you behaved differently. 
Before you smoked the cigarette, you felt in control of 
your smoking. Now you question this. Your uncontrolled 
behavior (smoking) is in direct opposition to your self-
image of an exsmoker. 
3. You blame yourself. You believe that you failed because of 
some weakness within you, e.g. lack of willpower, inadequacies, 
weakness, or being addicted. 
4. You feel terrible. You experience feelings like guilt, 
anger, or anxiety, because you did not control your urge to 
smoke 
5. The stage is set. Experiencing these negative emotions and 
cognitions about smoking, the stage is set for continued 
smoking. You have failed and might as well give up your 
smoking program entirely. This would result in the loss of 
all the benefits you would have gained had you resumed not 
smoking. 
How to break the AVE 
Now that you are aware of the AVE, you can cope with the situation 
of a lapse. Here's how. 
1. Use your analysis of high-risk situations. Specify the skills 
you need to learn to cope with these situations. Practice 
these skills whenever you experience the urge to smoke 
and remind yourself that in coping you are enhancing your 
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sense of self-efficacy. 
2. If a lapse occurs and you smoke--don't be alarmed. Recall 
that many people experience setbacks. 
3. Sit down and relax while you are planning what to do. 
Remember your contract limiting the extent of use. 
4. Remind yourself that no one is perfect all the time. Just 
because you had a cigarette does not mean that you are a 
failure or weak. You do not have to give up your nonsmoking 
program. 
5. Talk to someone who is sympathetic and helpful. 
6. Go immediately back to your nonsmoking program. It is 
extremely important for you not to say, "I blew it, I'm 
weak, I might as well continue to smoke. I can't stop." 
You will only add to the problem by continuing to smoke. 
If you smoke 
Your success in this treatment will depend on your perseverance 
and your use of coping skills. Being human, it is possible that you 
will experience a lapse and smoke a cigarette. If you do, take 10 
minutes out and remind yourself of the following facts. 
1. To err is human. A lapse is not all that unusual. It does 
not mean that you have lost control or have no willpower. 
It does not mean that you are a treatment failure. It 
does not mean that all previous efforts to quit were in vain. 
It does not mean that further smoking is inevitable. Do 
not catastrophize. 
2. It does mean that you need to be aware of your immediate 
thoughts and feelings. It does mean that you have to cope 
with your urge to smoke immediately. 
3. Make a commitment to learn from this lapse. 
4. Try not to feel guilty, frustrated, or angry. If these 
feelings persist, remember that they will pass. Remember 
that a lapse does not mean that you have to continue to smoke. 
Do not punish yourself. 
5. Your goal remains the same: to avoid smoking a cigarette. 
Be aware of the cop-out in thinking "I have already blown it. 
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I'm weak, I might as well smoke". Remember, one smoke does 
not make a smoker. 
6. To focus your attention away from the negative, destructive 
thinking and toward the positive, coping thoughts, complete 
the attached worksheet. Ask yourself, "What about this 
situation caused me to smoke?" "What do I need to learn or 
practice to avoid smoking in the future?" Remember your 
alternatives to high-risk situations. 
Note. This material was adapted from Boelens (1980). 
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POSITIVE ADDICTIONS 
In order to develop or maintain a healthy lifestyle, it is 
important to relax, enjoy life, and be free of stress. To accomplish 
this, it is sometimes necessary to program these types of activities 
into one's lifestyle. Glasser (1976) has devised the following 
criteria for activities or behaviors that are positive addictions: 
1. It is something noncompetitive that you choose to do and 
can devote"approximately an hour to per day. 
2. It is possible for you to engage in the activity easily 
and does not require a great deal of mental effort to do it 
well. 
3. You can do it alone or with others. It should not depend 
on the presence of others. 
4. You believe that it has some value for you (physical, mental, 
spiritual, etc.). 
5. You believe that with persistence and practice, you will 
improve at this activity. This needs to be a subjective 
measure as you are the only one who should measure that 
improvement. 
6. The activity must be one in which you can engage without 
criticizing yourself. If you can't accept yourself during 
this activity, it will not be addicting. 
Take note of the possibilities generated by the group and add 
your own to the list. 
Some examples include meditation, jogging, hobbies, reading. 
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WANT/SHOULD RATIO 
Individuals differ in the amount of time they spend doing things 
that they want to do and things that they feel they should or 
have to do. Many people place priority on doing the activities they 
should do, leaving any pleasurable activities until the end of the 
day or even the end of the week. Many times, this type of lifestyle 
leads to feelings of deprivation, abuse, and depression. Researchers 
have found the lack of pleasurable activities is a major cause or 
factor in depression. Thus, emphasizing the shoulds in life to the 
detriment of the pleasurable wants results in a need for indulgence 
(e.g. eating, smoking) and/or depression (which is also a high-
risk situation for many smokers). It is strongly suggested that 
you analyze your own lifestyle to determine if an imbalance exists. 
If so, it is important for you to plan pleasurable activities during 
each day. This is essential, not only to keep from resuming smoking, 
but to improve or maintain your mental health. 
A worksheet is attached in order to facilitate your analysis. 
Choose one weekday and one day of the weekend and fill out the daily 
activity log. Also, include a pleasure rating where you rate these 
activities according to the fun you have. A should = 1 and a want 
=7. If your ratio reflects that you spend most of your time in 
depressing, should, stressful activities, you need to be aware of 
the effects this can have on you. Make an effort to enjoy life. 
Plan pleasant events! 
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ACTIVITY LOG 
Day 1 activity list and pleasure ratings 
1. P_2. 
2. P_^ 
3. P_2. 
4. 
5. P = 
6. P_2_ 
7. P = 
8. P_2_ 
9. P_^ 
10. P = 
Day 2 activity list and pleasure ratings 
1. P_^ 
2.  ^  
3. P_2_ 
4. P_2_ 
5. P^ 
6. P = 
7. P_^ 
8.  
9. P = 
10. P = 
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GROUP COHESION QUESTIONNAIRE 
Please rate each of the following statements on a scale of 
1 to 7. The rating indicates your opinion about the statement. 
Please be honest. 
1. I feel the group should have met more often. 
2. I dislike my group. 
3. If most of the members of my group decided to dissolve 
the group by leaving, I would like an opportunity to 
dissuade them. 
4. I feel that working with the smoking group has enabled 
me to quit smoking. 
5. If I could have replaced members of my group with other 
"ideal group members" I would have (exclusive of group 
leaders). If yes, how many? 
6. I felt like I was included by the group in the discussions 
and activities. 
7. The length of the meetings should have been shorter. 
8. Compared to other therapy groups, I would imagine this 
group worked well together. 
9. The contracts were not useful. 
10. The therapists were competent. 
Please answer the following questions as honestly and completely 
as possible. We need your reactions and opinions in order to 
further improve our procedures. 
11. How do you feel about your participation in, and contribution to 
the group work? 
1 2 3' 4 5 6 7 
Strongly 
Disagree 
Strongly 
Agree 
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12, How do you feel about the group therapist? 
13. Did you employ the techniques/suggestions from the group sessions? 
Please detail what you used to cope and if this was useful. 
14. Any other reactions, suggestions, comments? 
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RELAPSE INTERVIEW 
Background information 
Client name 
Group description 
Date 
Questions 
1, When did you first begin to smoke again? 
(Fix a day/date or at least an approximate number of days after 
the quit date.) 
2. When you smoked that first cigarette, what was happening? Can 
you describe the occasion? 
a. Day and time 
b. Place 
c. Who else was there 
d. Were they smoking? 
e. What were you doing? 
f. How were you feeling before you smoked? 
g. Where did the cigarettes come from? 
h. Had you thought about smoking before that occasion? 
3. How did that first cigarette taste? 
a. unusually good 
b. pretty good 
c. about the same as they used to 
d. worse than usual 
191 
e. really bad 
Which of these statements best describes your emotional reaction 
after you smoked the first cigarette? 
a. fëlt good to be smoking again 
b. no particular feelings 
c. felt a mild degree of gui It/regret 
d. a lot of gui It/regret 
How many cigarettes did you smoke the first time? i 
The next day (or after that first episode) did you continue to 
try to control your smoking? 
a. How many cigarettes a day are you now smoking? 
b. What brand are you now smoking? 
c. How long (days/weeks) did it take you to go back to regular 
smoking? 
Which of the following statements best describes how your 
confidence in your ability to resist smoking changed in the 
days/weeks/months prior to your starting to smoke again. 
a. As time went on after quitting, I became more and more 
confident in my ability to resist smoking. 
b. As time went on after quitting, I became slightly 
more confident in my ability to resist, but not a 
lot more confident. 
c. Right up until the time I had that first cigarette in 
my mouth, my level of confidence was unchanged. 
d. As time went on after my quit date, I became somewhat 
less confident in my ability to resist but not a lot 
less confident. 
e. As time went on after my quit date, I became less and 
less confident in my ability to resist until I had very 
little confidence at all. 
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Which of the following best describes the effect of that first 
cigarette on your confidence in your ability to resist further 
cigarettes? 
a. It had little or no effect on my confidence in my 
ability to resist. I felt in control over my smoking 
habit. 
b. It had a moderate effect. . . It made me feel like 
I might be less able to resist. 
c. It had a strong effect ... It made me feel much 
less able to resist. 
d. It completely wiped out my confidence in my ability 
to resist the urge to smoke. I realized at that 
point that I had no control any more. I was a 
smoker again. 
What could your treatment program at the smoking clinic have 
included that could have helped you to remain abstinent? 
Is there anything else about your starting to smoke again that 
you think might be important? 
